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Abstract 
 
Headache is a common complaint with increasing prevalence in the third 
decade. Because it is so common, headache gives rise to substantial financial costs to 
society. In addition headache burdens both the health care system and the family.  
Headache is a symptom arising from a range of different disorders. 
Consequently, classification of headache is important, as a successful outcome is 
only likely if intervention is targeted to the underlying cause. For example 
cervicogenic headache (CGH) appears to be uniquely amenable to physical 
intervention.  
Differential diagnosis of migraine and CGH is a common clinical challenge 
made difficult by symptom overlap and the presence of multiple headache forms 
(MHF). Consequently incorrect headache diagnosis is common. In individuals with 
headache symptom overlap, classification of CGH is based on physical examination. 
Cervical movement impairment is reported to be an important factor in CGH 
diagnosis. The flexion-rotation test (FRT) is an easily applied form of movement 
analysis, the aim of which is to identify C1/2 segment movement impairment.  
The general aim of this doctoral research was to analyze the clinical 
effectiveness of the FRT in CGH diagnosis. The FRT was evaluated in a series of six 
studies, which will be presented in sequence and grouped in Parts A, B, and C.  
Part A consisted of two studies. The first was designed to investigate the long-
term stability and reliability of FRT measurements over time. Twenty-five subjects, 
15 with CGH, were assessed using the FRT on 4 occasions spread over two-weeks. 
For subjects with CGH there was no significant change in FRT range of motion over 
days. Reliability was excellent and minimal detectable change was at most seven 
degrees.  
The second study in Part A was designed to investigate the diagnostic 
accuracy of the FRT. Sixty subjects with headache (20 with CGH, 20 with migraine 
and 20 with MHF) were evaluated using the FRT. The results demonstrate 
significantly greater deficits in range of motion in CGH. Based on the FRT, an 
experienced examiner was able to make the correct diagnosis of CGH 85% of the 
time. The cut-off value for a positive FRT was 30˚. 
  vi 
Part B consisted of two further studies designed to determine the validity of 
the FRT as a test of cervical movement impairment at, and pain arising from, the 
C1/2 segment. The aim of the first study was to measure rotation from the occiput to 
the C4 vertebra with the neck in neutral position and in flexion using Magnetic 
Resonance Imaging. Nineteen asymptomatic subjects were evaluated. There was a 
significant difference in the pattern of cervical segmental rotation between axial 
rotation and the FRT. At the C0/1 segment, there was negligible range recorded in 
either position. In contrast, the most mobile segment was C1/2, providing the 
majority of rotation during the FRT.  
The aim of the second study, in Part B, was to investigate the impact of lower 
cervical joint pain on the FRT. Twenty-four subjects were evaluated, 12 with CGH 
and 12 with lower cervical joint pain. A single examiner conducted the FRT. 
Subjects with lower cervical joint pain were evaluated using the FRT prior to 
therapeutic cervical spine block procedure and were excluded if they did not gain 
complete pain relief following that procedure. Range of rotation during the FRT was 
significantly less in the CGH group. Sensitivity and specificity for CGH diagnosis 
was 75% and 92% respectively. The cut-off value for a positive FRT was 32˚. 
Part C consisted of two final studies designed to determine the clinical utility 
of the FRT in CGH evaluation. The aim of the first study was to investigate the 
reliability of manual examination and the frequency that segments above the C4 
vertebra were the dominant source of symptoms in CGH. Eighty subjects were 
evaluated, 60 with CGH, and 20 who were asymptomatic. Two examiners evaluated 
each subject with standard manual examination procedures. Each examiner 
independently rated each segment for pain and dysfunction. The C1/2 segment was 
found to be the most commonly agreed dominant source of symptoms, with positive 
findings at this level in 63% of cases. Other segments were less frequently dominant. 
The aim of the second study in Part C, was to investigate the association 
between the presence and severity of CGH symptoms and the impairment in range of 
motion measured during the FRT. Ninety-two subjects were evaluated, 72 with CGH 
and an additional 20 asymptomatic subjects. A single experienced examiner 
conducted the FRT. Range of motion was significantly reduced by 6˚ in the presence 
of headache at the time of testing. Furthermore, half the variance in FRT range of 
motion was explained by an index of headache severity, or component parts.  
  vii 
This series of studies has highlighted the central role that the FRT should play in the diagnosis of CGH. CGH principally arises from dysfunction of the C1/2 
segment, although usually more than one segment is involved. Determining 
dysfunction at the C1/2 segment can be reliably achieved by using the FRT as well 
as manual examination procedures. The FRT, in contrast to manual examination, is 
an easily applied clinical test that is reliable, when used by experienced or 
inexperienced examiners. Measurement and interpretation of the FRT is stable over 
time. Range recorded during the FRT is related to the severity of headache 
symptoms. The presence of pain arising from segments other than C1/2 does not 
influence interpretation of the FRT. Finally, the similarity of headache characteristics 
but difference in cervical spine range of motion deficits (specifically the FRT) 
between those with migraine and those with CGH highlights the importance of the 
FRT in headache evaluation. 
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1.1 INTRODUCTION 
Headache can be defined as pain in the head that can arise from many 
disorders or may be a disorder in itself. In broad terms headaches may be classified 
as primary, where there is no other causative factor, or secondary where the 
headache occurs in close temporal relationship to another disorder to which it is 
attributed. Primary headache disorders include migraine, tension-type headache 
(TTH), cluster headache, trigeminal autonomic cephalalgias and other primary 
headache. Secondary headache disorders are numerous and include headache 
associated with head trauma, vascular disorders and headache or facial pain 
associated with disorder of cranium, neck, eyes, ears, nose, sinuses, teeth, mouth or 
other facial or cranial structures. Included within the secondary headache category is 
cervicogenic headache (CGH) arising from a disorder of the neck. Further 
elaboration of the forms of primary and secondary headache will be presented later 
in this review. 
Headache is the most prevalent pain condition, ranked within the top ten 
causes of disability, affecting the majority of the global population and present at all 
stages of life (World Health Organization 2001). It is also one of the top five causes 
of disability in women (World Health Organization 2001). 
The lifetime prevalence of headache for all ages is reported as 66% and 
current one-year prevalence is 47% (Stovner and Hagen 2006). A prevalence rate of 
47% indicates that headache represents a major health problem. One-year prevalence 
rates are the more useful indicator as they provide a better understanding of disease 
burden. People who suffer from headache are more likely to remember headache 
frequency in the previous year than they are over a lifetime. One-year prevalence is 
higher in females (52%) and lower in males (37%) (Stovner and Hagen 2006) 
peaking in the second and third decade of life. It then slowly declines with increasing 
age, such that by the eighth decade headache prevalence is half that of earlier years 
(Radtke and Neuhauser 2009).  
Headache prevalence rates are not consistent across continents. For example 
one-year prevalence in Australia is 50% but only 21% in Africa (Stovner et al 2007). 
Possibly, headache burden varies considerably between different parts of the world, 
owing to differences in genetic background, climatic and socioeconomic conditions, 
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life-style, other disease spectrum and general health (Stovner et al 2007). For 
example a recent survey in Germany revealed that a higher level of education was 
associated with a higher prevalence of headache (Radtke and Neuhauser 2009). In 
addition in the United States, the lowest prevalence of migraine was observed among 
Asian-Americans, intermediate estimates were reported in African-Americans, and 
the highest prevalence estimates were observed among Caucasian-Americans, before 
and after adjusting for demographic covariates (Stewart et al 1992). An alternative 
explanation for the low prevalence rates in some countries may be that headache is a 
minor concern in comparison to other health and life issues and may simply be 
under-reported. 
 
1.2 THESIS RATIONALE 
It is clear that headache diagnosis and classification is important when it 
comes to providing effective management. This is particularly important when using 
physical treatment for headache. Only CGH appears to respond to physical 
intervention (Bronfort et al 2004).  
The difficulty of diagnosing CGH lies in the commonality of symptoms with 
other headache forms such as migraine. People who suffer from CGH or migraine 
complain of symptoms in the head and neck, and even associated symptoms of 
nausea, photophobia, or phonophobia. Although the prevalence of these features is 
more common in migraine, they still occur in patients with CGH. Hence the 
International Headache Society (IHS) classification system does not readily 
distinguish migraine from CGH, and an incorrect diagnosis may occur. An additional 
complication in headache diagnosis is that it is common to find individuals with 
headache who have multiple headache forms (MHF), rather than a single headache 
disorder. This may account for the mixture of headache symptoms in many 
individuals with headache. 
The flexion-rotation test (FRT) is a clinical test of movement impairment, 
purportedly biased to assess dysfunction at the C1/2 motion segment (Stratton and 
Bryan 1994; Hall et al 2008). This test appears to show early promise in CGH 
evaluation. For example diagnostic accuracy has been demonstrated in highly 
selected homogenous groups of patients with migraine with aura, CGH or healthy 
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controls (Ogince et al 2007; Hall et al 2008). In addition the FRT has high levels of 
inter-tester and intra-tester reliability on a test and re-test basis (Hall and Robinson 
2004; Ogince et al 2007; Hall et al 2008). Furthermore there is preliminary evidence 
that the FRT may be useful in determining treatment success (Hall et al 2007). 
However, further studies are required to develop these preliminary investigations. 
Hence, the purpose of this thesis is to examine the FRT as a diagnostic tool in the 
evaluation of CGH.  
This thesis will consist of a series of six studies, which will be presented in 
sequence. Each study will address different components of the overall thesis 
objective, which is to determine the diagnostic utility of the FRT in CGH evaluation. 
These studies are grouped into three components: 
1. Part A will consist of two studies designed to determine the long-term 
stability, minimal detectable change, and diagnostic accuracy of the FRT in 
CGH evaluation. 
 
2. Part B will consist of two further studies designed to determine the validity 
of the FRT as a test of cervical movement impairment at, and pain arising 
from, the C1/2 segment. 
 
3. Part C will consist of two final studies designed to determine the clinical 
utility of the FRT in CGH evaluation 
Prior to the commencement of these doctoral studies, ethical approval was 
sought for the studies conducted in Australia and granted by the Human Research 
Ethics Committee of Curtin University of Technology (see Appendix 10.1). Likewise 
ethical approval was sought for the study conducted in Japan and granted by the 
Japanese Society of Physical Therapy Science, prior to that study’s commencement 
(see Appendix 10.1).  
The purpose of the following chapter is to provide an overview of the relevant 
background literature in relation to the burden, classification, differential diagnosis 
and management of headache. Particular emphasis is given to migraine and CGH, 
due to their similarity. Similarity in terms of symptoms, but wide disparity in terms 
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of underlying pathomechanisms and response to physical treatment. The information 
contained in this chapter reinforces the importance of identifying accurate, valid and 
reliable clinical tools of CGH diagnosis, such as the FRT. 
Chapter 2 - Literature review 
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2.1 BURDEN AND DISABILITY OF HEADACHE 
The term ‘burden’ may cover all types of disease impact, but often it is a 
designation of impact in non-economic terms. Estimates of the burden of headache 
have been largely underestimated (Harpole et al 2005) and traditionally headache 
disorders have been seen as trivial and undeserving of medical care (Martelletti et al 
2007). To counteract this a global campaign was launched to identify and reduce the 
burden of headache (Steiner 2004). In support of this campaign it has been stated that 
headache disorders are a major clinical problem and should be a public health 
priority. This is because of their high prevalence, spread across genders and ages, 
duration (most are life-long conditions) and their imposition of disability and 
restricted participation upon those affected by them (Martelletti et al 2007).  
Some indication of the burden of headache was identified by a telephone 
survey of a representative sample of the general population in Germany (Radtke and 
Neuhauser 2009). In this survey of 7341 people, 60% of respondents reported 
headache, 60% of whom suffered from severe headache. Radtke & Neuhauser (2009) 
indicated that almost one-quarter of people in their survey with headache had 
frequent attacks (more than 20 days in the previous year). Furthermore 3% of the 
total sample reported chronic headaches, defined as more than 10 days in the past 4 
weeks. For the purpose of the study, disability because of headaches was defined as 
the inability to perform usual activities at work and in everyday life during at least 
one day in the previous year and was reported by 16% of all headache sufferers. 
Women suffered more often from severe and frequent headaches. As a consequence 
of their headache, women reported disability more often, and rated their health worse 
than men (Radtke and Neuhauser 2009). 
A number of headache sub-types cause substantially greater disability and a 
significant burden both to the individual and society as a whole (Stovner et al 2007). 
It has been estimated that TTH carries a higher burden than migraine due to the high 
prevalence, frequency and headache duration compared with other types of headache 
(Stovner et al 2007). Taking the total headache burden to be the sum of the burdens 
of migraine and of TTH, TTH was found to contribute 58% and migraine 42% 
(Stovner et al 2007). Furthermore, since headache in general was found to affect as 
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many as 50% of Europeans, this estimate, if true, would make headache a much 
more costly disorder than migraine alone (Stovner and Andree 2008). 
Migraine is a highly prevalent as well as a painful and costly disease (Smith et 
al 2010). Using 1994 data, the estimated economic burden of migraine in the United 
States of America was $14 billion per annum, with $1 billion in direct medical care 
(Hu et al 1999). A further $13 billion was accounted for by indirect costs related to 
lost productivity (Hu et al 1999; Oksanen et al 2006). A more recent assessment 
revealed direct medical costs were substantially higher at $11 billion per annum in 
2004 (Hawkins et al 2008). Similarly in Australia the direct and indirect financial 
costs of migraine have been estimated to be approximately half a billion dollars per 
annum (Schweitzer 1999).  
Part of the economic cost of headache is due to loss of productivity caused by 
absenteeism during acute headache attack. To quantify absenteeism from work a 
telephone survey was conducted on a random sample of the population (n=4007) 
aged from 16-65 in England. It was estimated that of a working population of 30 
million people, 100,000 are absent on any given day due to migraine. Over a year 
this would account for 25 million days of missed work or school in the United 
Kingdom alone (Steiner et al 2003). 
In addition to work absenteeism, part of the economic cost of headache arises 
from lost work productivity. Again most of the research has investigated migraine, 
where working with a headache is suggested to result in a 35% loss of self-reported 
work productivity (Berg and Stovner 2004). However, Pransky (2005) reported that 
objectively measured working efficiency reduced by only 8% in contrast to self-
reported working ability, which reduced by 20% (Pransky et al 2005). Based on 
findings such as these, it has been suggested that workers find creative ways to cope 
with the pain, and maintain standards of their work efficiency, even in the presence 
of severe headache (Stovner and Hagen 2006).  
As well as the financial cost to society, headache burdens the health care 
system. An estimate of this burden was determined from data collected by the 
National Hospital Ambulatory Medical Care Survey of Physicians working in 
outpatient clinics in the United States in 1997 (Schweitzer 1999). According to this 
analysis headache was the fourth most common cause of an emergency room visit. 
Based on the same survey from 1990-1998 the medical management of migraine in 
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the United States of America has been estimated to involve 5-9 million visits per 
year to primary care physicians (Gibbs et al 2003). As a consequence, headache 
surely impedes access to medical practitioners for people suffering from other 
conditions (Smith et al 2010). 
Headache also burdens the family, significantly disrupting family life, with 
impact on spouses, children, and friends. To investigate this Stang et al (2004) 
analyzed two large databases consisting of 4.3 million people in the United States of 
America. They compared families with and without a family member suffering from 
migraine. Total health care costs, work absence days, short-term disability, and 
workman’s compensation days all were higher among families with migraine than 
those without. As headache affects women more often than men and is most 
prevalent in the child rearing years, a substantial impact on family life might be 
expected. An on-line survey of 866 people with headache revealed that 90% of 
participants postponed household chores because of headaches, 30% canceled family 
and social activities during headache attack, and two-thirds feared letting others 
down because of their headaches (MacGregor et al 2004). Furthermore individuals 
with headache missed more days from family or leisure activities than from work or 
school (mean 4.2 versus 2.4 days).  
Lipton et al (2003) examined the influence of headache on family life both 
from the perspective of the person with migraine and from the perspective of their 
partner. A validated computer-assisted telephone interview identified 1142 people 
with migraine from a population sample of 8383 in England, and the United States of 
America. People who suffer from migraine, along with their partners, were 
interviewed about the impact of migraine on their participation in social, family and 
leisure activities and on family relationships. It was reported that at least 50% 
believed that they were more likely to argue with their partners or children as a result 
of their headache. In addition 52-73% reported other adverse consequences for their 
relationships with family members, and at work. A third of participants believed that 
their relationships would be improved if it were not for their headaches. When 
partners were questioned, 29% felt that arguments were more common because of 
headaches and 20-60% reported other negative effects on relationships at home 
(Lipton et al 2003). 
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Table 2.1- Distribution of perceived impact of headache on sub-modalities of 
function, relationships and emotions (Diener 2001) 
 
Sub-modality Specific impact Percent yes Percent no 
Impacting on 
function 
Forced to take time 
off work 47 53 
Loss of productivity 89 11 
Unable to do 
household chores 34 66 
Restricted in sport 32 68 
Impacting on 
relationships 
To spouse or close 
friend 86 14 
To dependents 42 58 
To colleagues 79 21 
Impacting on 
emotions 
Depression 35 65 
Isolation 33 67 
Anxiety 75 25 
Suicidal thoughts 12 88 
Anger 48 52 
 
Although other types of headache are less prevalent than either TTH or 
migraine they still cause considerable disability.  
Diener (2001) conducted a quantitative retrospective study of 450 patients’ 
perceptions of the impact of their CGH. High scores were reported for severe 
functional disability, for considerable emotional handicap and for negative impact on 
close relationships. Decreased productivity was reported by 89% of the population 
studied. Subjects expressed emotions of anxiety, anger and helplessness. Table 1 
shows the distribution of perceived impact on sub-modalities of function, 
relationships and emotions. Consequently CGH was considered to have severe 
impact on the health-related quality of life of individuals in this study.  
To compare differences in functional health status between healthy controls 
and people with CGH, migraine and TTH van Suijlekom (2003) used the medical 
outcomes study short form general health survey, which has eight generic health 
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domains. This is considered to be a valid and reliable tool to measure health related 
quality of life (Stewart et al 1988). Significant differences were found between 
healthy controls and people with CGH. In contrast there were no differences between 
people with TTH, migraine, and CGH for all domains except physical functioning. 
Physical functioning was significantly worse in people with CGH. The conclusion 
drawn from this study was that people with CGH have a quality of life burden that is 
substantial and is at least comparable to that of people with migraine and TTH.  
In addition to the financial and social consequences, headache causes 
psychological distress. Tenhunen et al (2005) found reduced quality of life in people 
who suffered from headaches on a daily basis. Using qualitative analysis they 
identified that beliefs and perceptions about loss of control were the central 
experiences mediating the impact of headache on the individual’s quality of life. 
Loss of control included cognitive, behavioural, emotional, as well as interpersonal 
aspects. Such information may potentially be of value in the development of 
interventions to enhance the quality of life in those affected.  
Population-based studies involving more than 11,000 participants have shown 
that headache is under diagnosed and under managed (Harpole et al 2005; Lipton et 
al 2001; Radtke and Neuhauser 2009). For example approximately 50 percent of 
persons with severe headache classified as migraine under IHS guidelines have never 
consulted a physician about their headaches (Lipton et al 2001). Similarly a recent 
German survey (Radtke and Neuhauser 2009) revealed that even when suffering 
from frequent headaches and considerable disability, less than half of those people 
with migraine sought professional care. Hence it would appear that many people are 
not receiving optimal management that should be available to them and the direct 
costs of managing headache are probably underestimated. On the contrary, given the 
evidence for effective treatment of headache, (to be presented subsequently), it is 
clear that many people with headache could benefit from consulting a health care 
practitioner and gaining access to specific treatment relevant to their headache 
condition. Such access could perhaps, substantially reduce the burden of headache to 
the individual and society as a whole.  
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2.2 CLASSIFICATION OF HEADACHE 
Examination and subsequent classification of headache is important to ensure 
that correct treatment is administered (Dodick 2010). The International Headache 
Society (IHS) in 1988 provided the first International Classification of Headache 
Disorders (ICHD-1) with specific definitions of the various headache types 
(Classification Committee of the International Headache Society 1988). This 
classification was later incorporated into the International Classification of Diseases 
(ICD-10) (International Headache Society 1997). The ICHD-1 was revised in 2004 
(ICHD-2) (Classification Committee of the International Headache Society 2004), 
but only minor changes were made with respect to the definitions of the most 
prevalent headache types.  
Classification of headache according to the ICD-10 is hierarchical 
(Classification Committee of the International Headache Society 2004). The level of 
detail regarding diagnosis is dependent on the requirements of the researcher or 
clinician. As outlined in Chapter 1, headaches may be classified as primary or 
secondary.  
Within these categories further sub-classification can be made. For example 
migraine is classified as with and without aura (ICHD 1.1 and 1.2). Further sub-
divisions are possible such as typical aura with migraine headache (ICHD 1.2.1) and 
typical aura with non-migraine headache (ICHD 1.2.2) with 4 other sub-types (ICHD 
1.2.3-1.2.6). CGH is coded ICHD 11.2.1 (Classification Committee of the 
International Headache Society 2004).  
Severely affected individuals may receive more than one diagnosis and have 
MHF. For example a single person may have both migraine without aura and 
medication overuse headache. Such diagnoses are listed in order of importance for 
the individual. Investigations of large cohorts of people with chronic headache reveal 
a substantial proportion with MHF (Pfaffenrath and Kaube 1990; Fishbain et al 2001; 
Amiri et al 2007). In a survey of the whole population of the town of Vaga in 
Norway 41 of 75 people were found to have a single headache form (CGH), while 
the remaining 34 had MHF (Sjaastad and Bakketeig 2007). The presence of MHF 
undoubtedly increases the difficulty of identifying the form of headache for each 
individual person who presents for assessment of his or her headaches.  
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Despite the IHS classification system, in one survey approximately 40% of 
those people with migraine who consulted a physician did not subsequently self-
report this diagnosis of migraine to other clinicians, suggesting problems with 
diagnosis, communication, or both (Edmeads et al 1993). Even when headaches are 
properly diagnosed, they may not always be correctly classified according to sub-
type. Data from the Landmark Study (Tepper et al 2004) in which participants used 
longitudinal diaries to record events, indicate that one in four people, with IHS 
defined migraine were not diagnosed with migraine by their primary care physicians.  
 
2.3 RELIABILITY OF HEADACHE CLASSIFICATION 
Despite the fact that it is more than 20 years since the IHS provided ICHD-1 
(Classification Committee of the International Headache Society 1988) there have 
been very few studies examining the reliability of the IHS classification system. In 
addition, to our knowledge, no study has investigated the reliability of the most 
recent modification of the IHS headache classification system in general clinical 
practice.  
One study has investigated the reliability of the IHS classification system in a 
hospital emergency department (Friedman et al 2007). Among the 480 subjects 
assessed, 25% had a secondary headache disorder, 64% had a primary headache 
disorder, 10% had a coexisting primary and secondary headache, and for 20% of 
subjects, neither a primary nor a secondary headache could be diagnosed. Of 309 
subjects with a primary headache, 60% had migraine, 11% had TTH, 1% had 
trigeminal autonomic cephalalgia, and 26% had an unclassifiable primary headache. 
However, a specific ICHD headache diagnosis could not be assigned to 36% of 
subjects examined. The emergency medicine investigators had a high level of inter-
observer agreement on the major sub-categories of primary headaches (agreement 
91%, kappa=0.86). In addition, there was a high level of inter-observer agreement on 
the overall categorization of secondary headaches (agreement 94%, kappa=0.86), but 
no attempt was made to examine reliability of further sub-categorization.  
In a small pilot study van Suijlekom et al (1999) investigated the inter-
observer reliability in distinguishing CGH from migraine without aura and TTH. 
Physicians from different areas of medical specialty examined 24 people with 
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headache using a semi-structured interview. Diagnosis for migraine and TTH was 
carried out in accordance with the IHS criteria and the criteria for CGH from 
Sjaastad et al (1998). Kappa statistics ranged upwards from 0.83 for physicians 
experienced in headache classification. Agreement was lower in those physicians 
without such experience. The conclusions drawn from this study were that reliability 
of classification of migraine, TTH and CGH were similar when using either IHS or 
Sjaastad et al (1998) classification criteria.  
Granella et al (1994) assessed inter-observer reliability of an earlier version of 
the IHS classification protocol for the diagnosis of primary headaches. In this study 
103 consecutive people with headache were assessed. Each person was given a 
structured interview recorded on videotape. Four experienced clinicians then 
reviewed the interviews separately and made a diagnosis of headache according to 
IHS criteria at the single digit level. The Kappa value was 0.74 indicating substantial 
agreement.  
In summary, headache is a common condition affecting both men and women 
at all stages of life. Estimates of the burden of headache have been underestimated 
which has led to a call for more research into all aspects of headache. Despite the 
high prevalence of headache and considerable cost burden many people with 
headache do not seek medical care and do not receive a diagnosis. Consequently 
individuals who suffer from headache may not receive the most effective treatment. 
The following section considers the classification of headache, which is important 
for headache diagnosis and subsequent management. 
 
2.4 PRIMARY HEADACHE - MIGRAINE 
2.4.1 Classification of migraine 
There are two sub-categories of migraine broadly differentiated by the 
presence of an aura that warns of a headache attack. An aura is defined as a 
reversible neurological event that usually lasts for 60 minutes after which the 
headache commences. Symptoms of migraine aura can be visual, sensory, language, 
or motor in nature (Kirchmann 2006). A visual aura is the most common, occurring 
in 99% of 163 cases of migraine with aura reviewed by Russell and Olesen (1996). A 
visual aura is a disturbance of vision consisting usually of flashes of light or dazzling 
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zigzag lines. Some patients complain of blurred vision, as though they were looking 
through thick or smoked glass. Sensory features of an aura occur in 31% of cases 
(Russell and Olesen 1996) and consist of a feeling of pins-and-needles experienced 
in the hand and arm as well as in the nose-mouth area on the same side as the 
headache. Symptoms spread up the arm and then extend to involve the face, lips and 
tongue. Motor symptoms are rare, occurring in only 6% of cases reviewed Russell 
and Olesen (1996). When present the condition is categorized as familial hemiplegic 
migraine (Classification Committee of the International Headache Society 2004).  
Premonitory or non-headache symptoms prior to the onset of headache need 
to be distinguished from an aura. Such symptoms include concentration problems, 
depression, food craving, physical hyperactivity, irritability, nausea, phonophobia, 
fatigue, sleep problems, stressed feeling, stiff neck and yawning (Schoonman, 2006). 
The prevalence of premonitory symptoms in migraine has been reported to occur in 
as many as 87% of a sample of 461 sufferers of migraine (Schoonman et al 2006) 
and as few as 12% (Rasmussen and Olesen 1992).  
Migraine without aura is more common and more disabling than migraine 
with aura because of a higher attack frequency (Classification Committee of the 
International Headache Society 2004). Estimates of one-year prevalence in the 
German adult general population, of equal gender mix, is 3.6% for migraine with 
aura and 10.6% for migraine without aura (Radtke and Neuhauser 2009). Higher 
prevalence occurs in females. In contrast, a recent survey of 27,840 white female 
health professionals aged over 45 revealed 18.4% reported migraine; 39.7% of which 
were categorized as migraine with aura (Schurks et al 2010). The difference in 
prevalence rates may be explained by differences in subjects in the two cohorts in 
these studies. In the German study the sample was taken from the general population, 
where as in the second study the sample consisted of middle-aged female health 
professionals.  
The IHS (Classification Committee of the International Headache Society 
2004) defines the diagnostic criteria for migraine with and without aura. The IHS 
criteria are shown in Table 2. 
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Table 2.2 International Headache Society classification criteria for Migraine 
(Classification Committee of the International Headache Society 2004) 
 
 Migraine without aura Migraine with aura 
A At least 5 attacks each fulfilling items B, C, and D 
At least 2 attacks each fulfilling B, 
C, and D 
B Headache attacks lasting 4-72 hours  
Aura consisting of at least one of the 
following, but no motor weakness: 
(i) Fully reversible visual 
symptoms including positive 
features and/or negative 
features  
(ii) Fully reversible sensory 
symptoms including positive 
features (ie, pins and needles) 
and/or negative features (ie, 
numbness). 
(iii) Fully reversible dysphasic 
speech disturbance. 
C 
Headache with at least two of the 
following characteristics:  
(i) Unilateral location 
(ii) Pulsating quality 
(iii) Moderate or severe intensity 
(iv) Aggravation by or causing 
avoidance of routine physical 
activity 
 
At least 2 of the following: 
(i) Homonymous visual symptoms 
and/or unilateral sensory 
symptoms.  
(ii) At least one aura symptom 
developing gradually over ≥5 
and/or different aura symptoms 
occurring in succession over ≥5 
minutes.  
(iii) Each symptoms lasting ≥5 and 
≤60 minutes 
D 
During headache at least one of the 
following: 
(i) Nausea and/or vomiting 
(ii) Photophobia and phonophobia 
 
Headache (fulfilling criteria B, C, 
and D for migraine without aura) 
begins during the aura or follows 
aura within 60 minutes 
E Not attributed to another disorder Not attributed to another disorder 
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Despite these criteria the diagnosis of migraine can be difficult and many 
patients receive an incorrect diagnosis (Pfaffenrath and Kaube 1990; Moeller et al 
2008). This may be explained by the complex nature of the symptoms or the 
presence of a number of different headache forms in the same patient. One study 
revealed that 33% of patients with CGH also met the IHS criteria for migraine 
(Vincent and Luna 1999). 
 
2.4.2 Cervical movement impairment in headache 
Neck pain and neck stiffness are common accompaniments of migraine 
(Schoonman et al 2006; Calhoun et al 2010). In addition there is a frequent 
association between headache and upper body musculoskeletal symptoms (Hagen et 
al 2002). Between 1995 and 1997 Hagen et al (2002), invited all 92,566 adults in 
Nord-Trondelag County in Norway to participate in a health survey. A total of 
51,050 (55%) people responded to questions concerning headache and 
musculoskeletal symptoms. Both migraine and non-migrainous headache were 
strongly associated with musculoskeletal symptoms. The prevalence of chronic 
headache (headache >14 days/month) was more than four times higher (OR = 4.6; 
95% CI 4.0-5.3) in the group of individuals with musculoskeletal symptoms than in 
those without. Individuals with neck pain were more likely to suffer from headache 
when compared with those with musculoskeletal symptoms in other areas. 
Due to the high presence of neck pain in migraine, it is understandable the 
presence of cervical musculoskeletal dysfunction in people with this headache form 
has been examined. A recent systematic review sought to evaluate the strength of the 
evidence for the role of cervical musculoskeletal dysfunction in migraine (Robertson 
and Morris 2008). In this review, electronic database searches up to April 2006 were 
performed, and 17 studies selected for review. Two independent reviewers using a 
customized checklist assessed the methodological quality of the included studies. 
The review found that inter-subject differences were inadequately reported and 
controlled. This resulted in grouping of participants with varying pathologies and 
symptoms. Furthermore, a diverse range of assessment procedures was used by the 
reviewed studies, which made comparison of their findings difficult. Despite these 
methodological flaws, this systematic review of the literature found that there is 
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currently no convincing evidence to confirm the presence of musculoskeletal 
impairment in migraine. 
Since this review a number of additional studies have investigated the 
presence of cervical movement impairment in different headache forms. In the 
studies published since 2006 there appears to be some disagreement as to the 
presence of cervical movement impairment in migraine. One study reported 
impairment (Bevilaqua-Grossi et al 2009) while others found no impairment 
(Oksanen et al 2006; Amiri et al 2007; Jull et al 2007). In each study cervical range 
of motion was assessed in a consistent manner, using the same measurement device. 
The discrepancy in study findings may be explained by the differences in subjects 
within the different study cohorts. Amiri et al (2007) investigated 108 community-
based volunteers with two or more concurrent frequent intermittent headache forms. 
Jull et al (2007) investigated 73 community-based volunteers, with migraine, TTH, 
and CGH. Oksanen et al (2006) investigated children in the community, with 
headache identified by a questionnaire. In that study 59 children had migraine, 65 
had TTH, and 59 were asymptomatic controls.  
In contrast, in the only study to find cervical movement impairment in 
migraine (Bevilaqua-Grossi et al 2009), female subjects only were selected from a 
headache clinic. Each group comprised 15 subjects of either transformed migraine, 
migraine without aura, or asymptomatic controls. People with transformed migraine 
had movement impairment in more directions of their cervical spine range of motion 
than people with migraine without aura. For individuals with migraine without aura, 
only cervical right rotation was significantly different from asymptomatic controls. 
However, no differences were found in cervical range of motion between 
transformed migraine and migraine without aura. These differences are not 
consistent with other reports (Oksanen et al 2006; Amiri et al 2007; Jull et al 2007). 
This difference may be accounted for by the small sample size, single female gender, 
and difference in subject recruitment in the study by Beviaqua-Grossi et al 
(Bevilaqua-Grossi et al 2009). 
If cervical movement impairment was a function of headache frequency, it 
would be expected that a greater reduction in cervical range of motion would be 
found in people with transformed migraine relative to those who had migraine 
without aura, but this is not the case (Bevilaqua-Grossi et al 2009). However the 
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study authors suggested that their study sample was not sufficiently large to expose 
such a difference.  
A single factor of cervical musculoskeletal function may not be sufficient to 
distinguish people with different headache forms. Jull et al (2007) examined a range 
of different markers of cervical musculoskeletal function in 73 community-based 
volunteers, of whom 22 had migraine, 33 had TTH, and 18 had CGH. Range of 
movement, manual examination of cervical segments, cervical flexor and extensor 
strength, the cranio-cervical flexion test, cross-sectional area of selected extensor 
muscles at C2 and cervical kinaesthetic sense were measured by a blinded examiner. 
There was no evidence that the cervical musculoskeletal impairments were present in 
the migraine and TTH groups. Findings indicated that a combination of factors were 
best able to identify CGH with 100% sensitivity and 94% specificity. The 
combination of factors included cervical movement impairment in the cardinal 
planes, in association with evidence on manual examination of upper cervical joint 
dysfunction and impairment identified by the craniocervical flexion test. While Jull 
et al’s (2007) report is very useful, further examination of different aspects of 
cervical movement impairment in migraine, particularly in patients with associated 
neck pain, are required to consolidate this information.  
 
2.4.3 Mechanisms of migraine 
The pathophysiological mechanisms underlying migraine remain poorly 
understood. Previously migraine was thought to be primarily a vascular disorder, or 
due to cortical spreading depression (spreading wave of depolarization of the brain). 
Recent reviews point to abnormality of brain function as the primary cause of pain 
leading to a chain of events in the periphery (Buzzi and Moskowitz 2005; Olesen 
2006; Goadsby et al 2009). Altered brain function consists of dysfunction or 
dysmodulation of sensory networks with the dominant disturbance affecting 
abnormal processing of essentially normal neural traffic (Goadsby et al 2009). Pain 
of migraine has been likened to neuropathic pain, but in migraine there is no nerve 
injury per se (Dodick and Silberstein 2006). In simple terms migraine pain can be 
thought of as an altered perception of normality, such that normal sensory input is 
misinterpreted as pain (Gantenbein and Sandor 2006).  
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Figure 2.1: Anatomy of the Trigeminocervical nucleus (adapted from Bogduk and 
Govind (2009)) 
 
The neuroanatomical substrate for migraine and other headache forms is the 
trigeminocervical nucleus (TCN), which lies in the upper cervical cord and brainstem 
(Figure 1) (Niere 2009). Migraine pain is experienced in the head and neck in the 
region innervated by the cutaneous afferents of the trigeminal and C1 to C3 nerves, 
all of which have input into the TCN (Robertson and Morris 2008). In this nucleus, 
trigeminal and cervical nociceptive afferents converge onto common second-order 
neurons in the trigeminal nerve spinal tract (Bogduk and Govind 2009).  
The migraine pain process is likely to be a combination of direct factors, i.e. 
activation of the trigeminal nociceptors supplying pain-producing intra- and 
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extracranial structures (dura mater, mucosal membranes of the sinuses, conjunctiva, 
eyelid and intracranial vessels among others), in concert with a reduction in the 
normal functioning of the centrally mediated endogenous pain control pathways that 
normally gate that pain (Goadsby et al 1991). Thus there are both central and 
peripheral mechanisms involved.  
Central sensitization of the TCN and peripheral sensitization of the trigeminal 
and cervical afferents is postulated as the essence of the pathophysiology of migraine 
and other headache forms (Dodick and Silberstein 2006; Niere 2009).  
The peripheral component of migraine involves the release of chemicals that 
increase nociceptor drive to an already sensitized TCN. Moskowitz (1990) suggests 
that the pain of migraine may be a form of sterile neurogenic inflammation. This 
may, in part, be explained by the release of a number of neurochemicals including 
substance P and calcitonin gene related peptide together with the formation of nitric 
oxide from sensory afferent terminals of the trigeminal nerve (Olesen 2008). Release 
of these chemicals causes intracranial plasma extravasation and other vascular 
changes (Goadsby et al 2009) inducing peripheral sensitization.  
Lending support for vascular dysfunction contributing to the peripheral 
component of migraine are studies showing that distension of the intracranial vessels 
causes referred pain in the ophthalmic division of the trigeminal nerve (Martins et al 
1993; Nichols et al 1993). However in people with migraine, dilation of blood 
vessels does not coincide with pain (Tegeler et al 1996). So it is probable that blood 
vessel dilation is a consequence of vasoactive peptides release associated with pain 
rather than the cause of pain itself (May et al 2001). Trigeminal nerve induced 
neurogenic inflammation may also explain the associated features of migraine, which 
include conjunctival injection, tearing and rhinorrhoea (Buzzi and Moskowitz 2005). 
Such associated autonomic like symptoms occur in up to 45% of those with more 
severe migraine (Urban and Gebhart 1999).  
Central modulation of the sensitization of the TCN is very complex and not 
clearly understood but may potentially involve a number of different higher centers 
including the cortex, thalamus and hypothalamus. These centers modulate the TCN 
and thereby influence the transmission of pain through descending inhibition acting 
through the nucleus raphe magnus (Lambert et al 2008) and ventrolateral 
periaqueductal grey (Goadsby et al 2009).  
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Lambert et al (2008) suggests that the nucleus raphe magnus is modulated by 
cortical mechanisms and experimental stimulation of this region of the brain causes 
marked inhibition of the TCN. In addition the inhibitory effects of the nucleus raphe 
magnus can be prevented by cortical spreading depression waves (the basis for the 
aura), further suggesting an indirect modulation of the TCN by cortical activation via 
the cortico- nucleus raphe magnus -trigeminal neuraxis.  
As postulated by Goadsby et al (2009), the ventrolateral periaqueductal grey 
appears to have influence on the TCN as experimental stimulation of neurons 
emanating from this region inhibits activity in the TCN. Similarly electrical or 
chemical stimulation of the hypothalamus causes inhibition of the TCN and thereby 
reduces nociceptive traffic through this nucleus. Thus the pathway for hypothalamus 
induced inhibition of the TCN is via the ventrolateral periaqueductal grey  
 
2.4.4 Management of Migraine 
Current management of migraine includes abortive medication, prophylactic 
drug therapy, non-pharmacological interventions (including physical treatment), and 
management of symptomatic medication overuse (Mueller 2007).  
A variety of different medication classes are used to abort headache including 
non-steroidal anti-inflammatory drugs used early in headache initiation and triptans 
or ergotamines for worsening headache (Hershey, 2010). Prophylactic medications 
are usually prescribed for people with more than four headache attacks per month. 
Medication is taken daily to reduce headache frequency, decrease headache intensity, 
and/or allow for improved abortive management of migraine (Mueller 2007). Drugs 
that have been used for prevention of migraine include anti-depressants, anti-
hypertensives, anti-histamines or anti-serotonergics, and anti-epileptics (Mueller 
2007). Despite published guidelines for the pharmacological management of 
migraine a sizable proportion of people who suffer from migraine use medications 
that are not first-line (Bigal et al 2009). 
Behavioural management includes cognitive behavioral therapy and bio-
behavioral training (ie, biofeedback, relaxation training, and stress management). 
Behavioral approaches to migraine management in conjunction with drug 
management show promise (Buse and Andrasik 2009). However, the availability of 
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programs to bring these approaches to people with migraine is limited, and their 
efficacy is not well established. Informing people about realistic treatment 
expectations, possible delayed efficacy of medications, and avoidance of headache 
triggers, may also be helpful in headache management (Mueller 2007).  
Physical treatments for migraine include massage therapy, physiotherapy, 
osteopathy and chiropractic among others (Biondi 2005). The reason people seek 
physical treatment for their headache is that they commonly experience neck pain 
either before or during a headache attack (Calhoun et al 2010). Hence they have a 
belief that their neck is the source of the head pain and treatment to the neck might 
alleviate it. Unfortunately quality studies are lacking to support the use of physical 
treatment for migraine (Biondi 2005). This finding was broadly supported by a 
Cochrane review of non-invasive physical treatments for chronic/recurrent primary 
headache (Bronfort et al 2004). That review concluded that the evidence associated 
with spinal manipulation indicates that it has only a short-term effect, similar to that 
of a commonly used, effective drug amitriptyline, but that study was of low-level 
methodological quality (Nelson et al 1998). In view of this, one published guideline 
did not recommend the use of manual therapy for the treatment of migraine (Scottish 
Intercollegiate Guideline Network 2008). 
Other possible treatment options with weaker evidence for effectiveness are 
electrotherapy modalities. For TTH, there is evidence that adding spinal 
manipulation to massage is not effective. The lack of evidence for manual therapies 
for TTH was also reported in a more recent review (Fernandez-de-Las-Penas et al 
2006). Hence it appears that physical treatment is not effective in the long-term 
management of patients with either migraine or TTH. 
The preceding section has described the incidence, pathophysiology, 
classification and management of primary headache disorders with an emphasis on 
migraine. From this information it can be concluded that primary headache such as 
migraine and TTH are not relieved by physical modalities. In the following section, 
secondary headache will be presented. In contrast to primary headache, there is 
evidence that physical treatment is effective for some forms of secondary headache 
such as CGH. This makes differentiation of CGH from primary headache very 
important, as it enables targeted intervention, which is likely to be more effective. 
For example in one small case series of people with headache originally diagnosed as 
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migraine, all of whom were un-responsive to treatment for migraine, all subjects 
gained long-term relief following treatment designed for CGH (Yi et al 2005). In that 
case series migraine was mistakenly diagnosed for CGH. As migraine and CGH 
share many clinical features (including the presence of neck pain and possibly 
cervical movement impairment) more research is required to investigate other means 
of differentiating between them. 
 
2.5 SECONDARY HEADACHE 
Secondary headache is defined by the IHS (Classification Committee of the 
International Headache Society 2004) as headache that occurs in close temporal 
relationship to another disorder to which it is attributed. In addition, headache is 
greatly reduced or resolves after successful treatment or spontaneous remission of 
the causative disorder.  
According to the IHS (Classification Committee of the International 
Headache Society 2004) the major categories of secondary headache include: 
“1. Headache attributed to head and neck trauma 
2. Headache attributed to cranial or cervical vascular disorder 
3. Headache attributed to non-vascular intracranial disorder 
4. Headache attributed to a substance or its withdrawal 
5. Headache attributed to infection 
6. Headache attributed to disturbance of homeostasis 
7. Headache or facial pain attributed to disorder of the cranium, neck, eyes, 
ears, nose, sinuses, teeth, mouth or other facial or cranial structures 
8. Headache attributed to psychiatric disorder” 
p. 7 
In addition to these 8 major secondary categories and 4 major primary 
categories, further sub-division is possible. For example CGH is coded as ICHD 
11.2.1, and is a sub-category of headache attributed to disorder of the neck. This 
category also contains ICHD 11.2.2 (headache attributed to retropharyngeal 
tendonitis) and ICHD 11.2.3 (headache attributed to craniocervical dystonia). 
The IHS lists more than 180 different forms of secondary headache 
(Classification Committee of the International Headache Society 2004), although 
more are described but not recognized or not listed by the IHS. Due to the large 
number of secondary headache forms, a detailed description of the prevalence, 
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pathophysiology, and clinical identification of each of these headache forms is 
beyond the scope of this thesis.  
As the headache symptoms of secondary headache are associated with many 
and varied disorders and pathophysiology, the underlying pain mechanisms are also 
likely to be many and varied. The principal mechanism underlying headache 
symptoms in the majority of secondary headache disorders is based on a concept of 
convergence. Nociceptive afferents converge onto common second-order neurons in 
the brainstem and upper part of the spinal cord, together with trigeminal nerve 
afferents (Bogduk and Govind 2009). This leads to a loss of somato-sensory spatial 
sensitivity. Hence afferent input from a secondary headache disorder (such as 
infection of the sinuses) leads to symptoms of headache. This concept is described in 
more detail in a subsequent section on CGH. 
It is important to recognize that, in contrast to primary headache, secondary 
headache arises from a wide variety of different specific disorders. Indeed, as part of 
the IHS classification criteria for secondary headache (Classification Committee of 
the International Headache Society 2004) the disorder must greatly reduce after 
successful treatment of the specific causative disorder.  
Thus in effect the diagnosis is made after the patient has recovered. These 
criteria have been recently questioned and a new set of criteria proposed (Olesen et al 
2009) that do not include section D of the IHS classification (Headache is greatly 
reduced or resolves within 3 months). These criteria are shown in Table 3. 
The reasoning upon which this change in headache classification is founded, 
is the need to emphasize the importance of diagnosis. Basically, it should be possible 
for medical practitioners to diagnose the patient at the time they present, rather than 
after treatment has been successful (Olesen et al 2009). The original classification 
was designed more for the purpose of classification to facilitate scientific discussion 
rather than for clinical practice. An incorrect initial diagnosis is likely to lead to 
treatment failure, as the underlying condition will not be adequately addressed.  
The incidence, pathophysiology, clinical evaluation, diagnosis and 
management of CGH will be extensively reviewed in Chapter 3. 
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Table 2.3 Criteria for classification of secondary headache (Olesen et al 2009) 
 
 Secondary headache 
A Headache of any type, fulfilling criteria C and D 
B Another disorder scientifically documented to be able to cause headache has been diagnosed 
C 
Evidence of causation shown by at least two of the 
following: 
1. Headache has occurred in temporal relation to the 
onset of the presumed causative disorder 
2. Headache has occurred or has significantly worsened 
in temporal relation to worsening of the presumed 
causative disorder 
3. Headache has improved in temporal relation to 
improvement of the presumed causative disorder 
4. Headache has characteristics typical of the causative 
disorder3 
5. Other evidence exists of causation 
D The headache is not better accounted for by another headache diagnosis  
 
Physical treatment has been shown to be effective for the long-term 
management of some but not all headache forms. Bronfort et al (2004) conducted a 
systematic review of randomized- and quasi-randomized controlled trials of non-
invasive physical treatments used to treat different forms of chronic or recurrent 
headache. These authors searched a range of databases from their inception to 2002. 
Two independent reviewers abstracted trial information and scored trials for 
methodological quality. Outcome data were standardized into percentage point and 
effect size scores wherever possible. Subsequently these data were analyzed to 
determine the strength of the evidence of effectiveness using pre specified rules.  
Twenty-two studies with a total of 2628 people (age 12 to 78 years) met the 
inclusion criteria. Five types of headache were studied: migraine, TTH, CGH, a mix 
of migraine and TTH, and post-traumatic headache. Ten studies had methodological 
quality scores of 50/100 or more, but many methodological limitations were 
identified. The conclusions from this review were that for the prophylactic treatment 
of CGH, there is evidence that physical treatment is effective. In contrast, as 
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previously presented, the physical treatment of people with migraine and TTH could 
not be supported.  
Based in the information available in the literature, it is apparent that 
successful treatment using physical intervention is dependent on ensuring that only 
people with CGH receive this form of intervention. For example headache attributed 
to disorder of the sinuses is unlikely to respond to manual therapy of the cervical 
spine. Likewise headache associated with substance abuse is also unlikely to respond 
to such form of treatment. It is therefore apparent that accurate differential diagnosis 
is essential to ensure that appropriate treatment can be provided.  
 
2.6 SUMMARY OF CHAPTER 2 
Headache is common complaint with increasing prevalence in the third 
decade. Although men and women report headache, women suffer more often from 
severe and frequent headaches. Due to its commonality, headache gives rise to 
substantial direct and indirect financial costs to society, causing absenteeism and loss 
of work productivity. As well as the financial costs, headache burdens the health care 
system and is one of the most common reasons for an outpatient medical 
consultation. In addition headache burdens the family, disrupting family life, with 
adverse consequences for relationships with partners, children and friends.  
Classification of headache is important for management and is based on 
guidelines published by the IHS. Headaches may be classified as either primary 
where there is no other causative factor, or secondary where the headache occurs in 
close temporal relationship to another disorder to which it is attributed. Primary 
headache includes migraine without aura, many symptoms of which are similar to 
CGH, which is a secondary headache form. Consequently classification of headache 
on IHS guidelines is difficult and misdiagnosis is common. Although the IHS criteria 
have been in place for over 20 years there has been little in the way of research to 
identify the reliability and validity of the classification system. 
Evaluation of functional health status for people across different headache 
sub-types reveals similar levels of disruption of quality of life in a range of different 
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domains. However, people with CGH have substantially greater loss of physical 
function than people with migraine or TTH.  
The pathophysiological mechanisms underlying primary headache remain 
poorly understood but are believed to involve abnormal brain function together with 
sensitization of trigeminal nociceptors supplying pain-producing intra- and 
extracranial structures. This is in contrast to the mechanisms underlying secondary 
headache, including CGH. Convergence of cervical nociceptive afferents onto 
common second-order neurons in the trigeminal nerve spinal tract is the underlying 
basis of CGH. 
Due to the presence of neck pain, people who suffer from primary headache, 
including migraine, frequently seek physical treatment to the neck. The belief is that 
treatment will relieve their headache. However, unlike CGH, the available evidence 
does not support the use of physical treatment for the management of primary 
headache. In view of this, guidelines for managing headache do not recommend the 
use of physical treatment for the treatment of migraine. Hence the importance of 
distinguishing subjects with CGH from subjects with migraine.  
As CGH and migraine share many clinical features (including the presence of 
neck pain and possibly cervical movement impairment) more research is required to 
investigate other means of differentiating between them. Accurate diagnosis depends 
on a range of factors, which are presented in the following paper. Information related 
to the management of CGH will be presented subsequently to conclude this review.  
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3.1 CLINICAL EVALUATION OF CERVICOGENIC HEADACHE 
 
The clinical evaluation and diagnosis of CGH are examined in detail in the following 
paper. 
Hall TM, Briffa K, Hopper D. Clinical evaluation of cervicogenic headache. Journal 
of Manual and Manipulative Therapy 2008; 16(2): 73-80 
Permission to reproduce this paper was sought and subsequently granted by the 
publisher. 
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3.2 MANAGEMENT OF CERVICOGENIC HEADACHE 
Although there have been many treatments suggested for CGH, few have 
been tested and even fewer have been proven successful (Bogduk and Govind 2009). 
Treatment varies from pharmacological management to invasive procedures such as 
joint arthrodesis, cervical fusion, radiofrequency neurotomy and steroid injections 
into facet joints. All of the invasive, procedures are costly, with many showing 
limited evidence of success (Bogduk and Govind 2009).  
In contrast, physical treatment is non-invasive and there is at least moderate 
evidence of success based on a number of different systematic reviews of the 
literature (Bronfort et al 2004; Gross et al 2004; Fernandez-de-Las-Penas et al 2005; 
Bronfort et al 2010). Physical treatments include manipulation, mobilization, 
exercise, massage, electrotherapy modalities, and acupuncture among others. In the 
most recent systematic review Bronfort et al (2010) examined the scientific evidence 
regarding the effectiveness of manual treatment (not including exercise) for the 
management of a variety of musculoskeletal and non-musculoskeletal conditions 
including CGH. In this review only randomized controlled trials and evidence-based 
clinical guidelines were included and were identified by database searches. All 
publications were formally quality-assessed by two reviewers using a scale assessing 
the risk of bias recommended for use in Cochrane systematic reviews. This review 
found moderate quality evidence that spinal manipulation is more effective than 
placebo manipulation, friction massage, and no treatment. In addition there was 
moderate quality evidence that self-mobilizing natural apophyseal glides are more 
effective than placebo but inconclusive evidence in an unclear direction for the use 
of mobilization.  
Since this systematic review, additional studies have shown that physical 
treatment is effective for the prophylactic management of CGH (Haas et al 2010a; 
Haas et al 2010b). In the study by Haas et al (Haas et al 2010a) 80 participants were 
randomized to receive spinal manipulation or a control. Improvements in CGH in the 
prior four weeks were dichotomized into a binary outcome at two thresholds: 30% 
representing minimal clinically important change and 50% representing clinical 
success. Groups were compared at 12 and 24-week follow-up using binomial 
regression to compute the adjusted risk difference between groups and number 
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needed to treat after adjusting for baseline differences between groups. For headache 
pain, clinically important improvement (30% or 50%) was more likely for spinal 
manipulation. The conclusion from this study was that spinal manipulation 
demonstrated a benefit in terms of a clinically important improvement of CGH.  
A novel form of physical management for CGH, described by Mulligan 
(2006), was investigated in a randomized controlled trial (Hall et al 2007). Thirty-
two subjects with CGH and a limitation of passive upper cervical range of motion 
were randomized into a specific novel exercise or placebo group. After an initial 
instruction and practice visit in the clinic, interventions consisted of exercises applied 
independently by the subject twice daily at home on a continual basis. Headache 
symptoms were determined by a headache index over time, assessed by 
questionnaire pre-intervention, at 4 weeks post-intervention, and at 12-months post-
intervention. Headache index scores were significantly less in the physical 
intervention group at 4 weeks and 12-months when compared to the placebo group 
with an overall reduction of 54% for the individuals in the physical intervention 
group.  
Success of physical treatment in the management of CGH relies in the first 
instance on an accurate differential diagnosis of a cervical musculoskeletal origin to 
the headache (Jull 1997). Physical treatment consists of preventative intervention 
together with intervention designed to relieve symptoms. Preventative intervention is 
aimed at addressing the underlying cause and should be expected to have a 
significant impact on headache characteristics including frequency, intensity and 
duration (Biondi 2005).  
Headache is a complex problem, involving multiple dimensions or aspects. 
Consequently, Andrasik et al (2005) have suggested that outcome of treatment for 
headache should be assessed using a range of different measurement tools. These 
tools should include headache diaries, headache symptom questionnaires, headache 
functional disability questionnaires as well as indices measuring headache burden 
and severity. In addition, because headache improvement can occur in a variety of 
ways, researchers are advised to include in their assessment of outcome different 
parameters evaluating all aspects of headache. These parameters include primary and 
secondary measures of headache. Primary measures of headache include attack 
frequency or headache days per month. Secondary measures of headache include 
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headache indices, headache duration, and peak headache severity. Additional 
parameters include secondary measures of disability and quality of life and 
secondary non-headache measures including medication consumption, psychiatric 
symptoms, stress and coping, and treatment satisfaction.  
Simply measuring headache frequency, intensity and duration as an outcome 
measure may be problematic as people tend to either underestimate or overestimate 
their symptoms depending on how they feel at the time they are asked (Wittrock and 
Foraker 2001). These memory biases mean that global, retrospective measures of 
headache can be heavily influenced by current pain experience and expectations 
(Andrasik et al 2005). Hence evaluating a range of headache parameters unrelated to 
pain intensity, frequency and duration are likely to give a clearer, bias free estimate 
of change. 
As cervical movement impairment defines CGH, it would seems reasonable 
to infer that reduction in impairment deficits should occur as CGH symptoms 
improve. It has been suggested that the FRT can be used as an outcome measure 
when managing individuals with CGH (Hall et al 2007). It is apparent that the FRT is 
a reliable measure of cervical movement impairment on a test-retest basis, but the 
stability of the measurement over time has not been tested. In addition the magnitude 
of error, or minimal detectable change (MDC), associated with the test is unknown. 
A final consideration, when using the FRT as an outcome measure, is the influence 
of pain at the time of testing on test interpretation and range of motion. All are 
important criteria when using the FRT to evaluate CGH over time.  
Typically symptoms of CGH are episodic in nature, spanning days or weeks 
between headache attacks. Management of CGH frequently requires long periods 
between evaluation sessions, to determine changes in headache symptoms. If the 
FRT is to serve as a useful measure of impairment in CGH evaluation, and to 
evaluate treatment outcome, then measurement of mobility recorded during the FRT 
must be demonstrated to be stable over time, with minimal error, in individuals with 
CGH.  
An additional consideration for the use of the FRT as an outcome measure is 
whether range of motion recorded during the test is related to the severity of 
headache symptoms. Findings from two studies (Hall and Robinson 2004; Ogince et 
al 2007) investigating this relationship are inconsistent. This inconsistency may 
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relate to the small sample size or homogenous nature of the samples in both studies. 
Knowledge of this relationship is important from a diagnostic point of view as well 
as for the use of the test as a treatment outcome measure. Further studies are required 
to determine the relationship between headache symptoms and range of motion 
deficits identified by the FRT. 
 
3.3 SUMMARY OF CHAPTER 3 
CGH is a sub-category of secondary headache with an estimated prevalence 
of 4.1% in the general population. Despite the low prevalence, people with CGH 
have a substantial quality of life burden comparable to migraine and TTH.  
Diagnostic criteria for CGH have been established but many of the subjective 
features of CGH are common with other headache forms, in particular migraine. 
Indeed studies have shown that an incorrect diagnosis may occur in 50% of cases. In 
addition more than one headache form may co-exist in any patient with headache. 
Hence CGH diagnosis relies heavily on physical examination. While there is some 
evidence of cervical musculoskeletal dysfunction in headache disorders other than 
CGH, it has been shown that collectively, restricted neck movement, in association 
with evidence on manual examination of upper cervical joint dysfunction and 
impairment in the deep neck flexors identified by the craniocervical flexion test, had 
100% sensitivity and 94% specificity to identify individuals with CGH from those 
with migraine or TTH.  
The FRT is one form of manual examination purported to identify symptoms 
arising from and dysfunction at the C1/2 segment, but the validity of this test has not 
been established. Test and re-test reliability as well as values for normal range of 
movement and range for subjects with CGH have been established. However long-
term stability and MDC of the FRT has not been tested. Such information is 
important when using the FRT over prolonged time periods, as is commonly the case 
when treating patients with CGH. In addition the diagnostic accuracy of the FRT has 
been established in homogenous, carefully selected populations where comparison 
groups were either migraine with aura or asymptomatic controls. However, no 
studies have investigated the diagnostic accuracy of the FRT in heterogenous groups. 
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For example, no study has investigated the diagnostic accuracy of the FRT in 
identifying CGH from migraine without aura or those with MHF.  
The presence of pain at the time of testing may influence range of motion 
recorded during the FRT. This may influence the diagnostic accuracy of the FRT in 
CGH diagnosis. In addition this may influence the examiners interpretation of range 
of motion data when the FRT is used as an outcome measure following an 
intervention for headache. No studies have investigated whether the presence of pain 
influence examiner interpretation of the FRT.  
There is also uncertainty about the relationship between headache symptoms 
and impairment measured by the FRT. One report found a strong correlation between 
an index of headache severity and range recorded during the FRT but another study 
did not. Further studies are required to investigate this. 
One final consideration regarding the diagnostic accuracy of the FRT is the 
frequency with which the C1/2 segment is the cause of CGH. The FRT is a more 
valuable clinical test if there is a high frequency of involvement of the C1/2 segment 
in CGH. The lower the frequency of involvement, then the lower the diagnostic 
accuracy of the test. Previously the author conducted a survey investigating the 
frequency with which the C1/2 segment is the cause of CGH, but the study was of 
low methodological quality (Hall et al 2003). In that study, the C1/2 segment was the 
most common symptomatic cervical segment. Further studies are required to 
investigate this. 
The studies undertaken to examine the issues identified related to the value of 
the FRT in establishing a diagnosis of CGH and its management will be presented in 
the following chapter. 
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The Studies 
 
Part A – Study 1 and 2 
• Reliability and diagnostic accuracy of the flexion-rotation test 
 
Part B – Study 3 and 4 
• Validity of the flexion-rotation test 
 
Part C – Study 5 and 6 
• Clinical utility of the flexion-rotation test 
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 Chapter 4: Part A 
Study 1 and 2 
• Reliability and diagnostic accuracy of the flexion-rotation test 
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4.1 RESEARCH QUESTIONS 
From the literature review it is apparent that the FRT is a reliable measure of 
cervical movement impairment but the stability of the measurement over time has 
not been tested. In addition the magnitude of error, or MDC, associated with the test 
is unknown. Both are important criteria, particularly when using the FRT to evaluate 
CGH, symptoms of which are episodic in nature, spanning days or weeks between 
headache attacks. Management of CGH frequently requires long periods between 
evaluation sessions, to determine changes in headache symptoms. If the FRT is to 
serve as a useful measure of impairment in CGH evaluation, and to evaluate 
treatment outcome, then measurement of FRT mobility must be demonstrated to be 
stable over time, with minimal error, in individuals with CGH.  
Hence the following research questions were developed for Study 1: 
1. Does range of motion recorded during the FRT and examiner interpretation of 
the test finding vary over days or weeks 
2. What is the error (standard error of measurement and MDC) involved in 
repeated measurement of the FRT over days or weeks? 
 
4.2 STUDY 1 OBJECTIVES 
The objectives of this study were to identify the long-term stability of the 
FRT measurements, to investigate the long-term reliability of test interpretation and 
to establish the MDC. 
As the FRT has been shown to have excellent sensitivity, specificity and 
examiner agreement in the diagnosis of CGH in highly controlled studies further 
studies were developed to evaluate the diagnostic accuracy of the FRT in “real 
world” clinical situations. In clinical practice people who suffer from headache 
frequently present with a range of different headache forms, sometimes with MHF in 
an individual person. The diagnostic challenge is to differentiate migraine from 
CGH, and to identify the presence of CGH in individuals with MHF. Hence there is a 
need to identify the diagnostic accuracy of the FRT in heterogeneous samples of 
people with CGH, migraine and MHF. 
Hence the following research questions were developed for Study 2: 
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1. What is the diagnostic accuracy of the FRT in differentiating people with 
CGH from migraine without aura and those with MHF  
2. Does range of motion values for the FRT differ in people with migraine, 
MHF and CGH? 
 
4.3 STUDY 2 OBJECTIVES 
The objectives of this study were to identify the diagnostic accuracy of the 
FRT in CGH evaluation. An additional aim was to compare the findings of the FRT 
between subjects with CGH, migraine without aura, and MHF. 
 
4.4 METHODOLOGY FOR STUDY 1 & 2 
 
4.4.1 Study design Study 1 
A repeated measures longitudinal design was used to investigate the stability 
of FRT measurements over time (days and weeks), to investigate the long-term 
reliability of test interpretation (weeks), and to establish the MDC in subjects with 
CGH. 
 
4.4.2 Study design Study 2 
A single blind comparative measurement study design was used to determine 
whether range recorded and examiner interpretation of the FRT differs between 
subjects with MHF and those with Migraine and CGH 
 
4.4.3 Sample size calculation  
Sample size estimate for both studies were based on data collected from 
previous studies (Ogince et al 2007; Hall et al 2008). 
 
4.4.3.1 Study 1 
A priori power analysis determined that a sample size of 15 subjects with 
CGH was required to obtain a statistical power of 0.80. This was based on 4 repeated 
measurements, with a predetermined coefficient of reliability of 0.9 and a calculated 
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effect size of 0.3 (Eliasziw et al 1994; Faul et al 2007). Ten asymptomatic subjects 
were included to reduce examiner bias but were not included in the analysis.  
 
4.4.3.2 Study 2 
Based on a single measurement of the FRT, with a standard deviation of 11 
degrees for range of motion, and a calculated effect size of 0.4 (Eliasziw et al 1994; 
Faul et al 2007), a priori power analysis determined that a total sample size of 60 
subjects (20 in each group, consisting of Migraine, CGH, or MHF) was required to 
obtain a statistical power of 0.80 with alpha set at 0.05.  
 
4.4.4 Subjects 
Recruitment for subjects in both studies was as follows: Subjects with CGH 
and migraine without aura were recruited in a manner of convenience through 
advertisements placed in local newspapers and through the University website. 
Asymptomatic subjects were volunteers recruited from Curtin University students.  
 
4.4.4.1 Inclusion criteria 
CGH - Subjects were selected based on criteria developed by the IHS 
(Classification Committee of the International Headache Society 2004) and 
Sjaastad (1998). These included a primary complaint of side dominant 
headache without side shift, headache preceded by neck pain, and headache 
precipitated or aggravated by neck movement or posture. Additionally 
headache frequency needed to be at least once per week and episodic 
headaches needed to have been present for more than the previous 3 months.  
 
Migraine - Subjects were selected according to the IHS diagnostic criteria for 
migraine without aura (Classification Committee of the International 
Headache Society 2004). These criteria are at least five headache attacks, 
each lasting 4-72 hours, which have at least two of the following 
characteristics: unilateral location; pulsating quality; moderate or severe 
intensity; aggravation by or causing avoidance of routine physical activity. In 
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addition one of the following is present during headache: nausea and/or 
vomiting; photophobia and phonophobia. Finally the headache may not be 
attributed to another disorder. 
 
MHF - Subjects were selected according to the IHS diagnostic criteria 
(Classification Committee of the International Headache Society 2004), 
where an individual with headache could be categorized as having more than 
one form of headache.  
 
Asymptomatic - In Study 1, asymptomatic subjects without neck pain or CGH 
were matched for age to the subjects with CGH.  
 
4.4.4.2 Exclusion criteria 
Subjects were excluded in either Study 1 or 2 if they had inability to 
communicate, inability to tolerate the FRT, if they were receiving physical treatment 
for their neck (for example physiotherapy or chiropractic), and if they did not 
provide informed consent  
 
CGH – Subjects with CGH were excluded if they had continuous headache 
for more than 48 hours and headache was not of cervical origin. 
 
Migraine – Subjects with migraine were excluded if the headache could be 
attributed to another headache form. 
 
Asymptomatic – Subjects were excluded if they had significant history of neck 
pain or headache (once per month or more). 
All participants were given a written information sheet explaining the 
procedure prior to testing and gave written consent. The Human Research Ethics 
Committee of Curtin University of Technology granted approval for this study. 
Subject information sheets, consent forms, and ethical approval documentation are 
presented in the appendix section (Chapter 10). 
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4.4.5 Variables 
 
4.4.5.1 Study 1 
Independent variables 
• Two groups - CGH and asymptomatic 
• Time (days) 
 
Dependent variables 
• Range of rotation to the left and the right (degrees) recorded during the FRT 
measured by a modified cervical range of motion device (CROM) 
• Examiner interpretation of the FRT (positive or negative) 
 
4.4.5.2 Study 2 
Independent variables 
• Groups – CGH, migraine and MHF 
 
Dependent variables 
• Range of rotation to the left and the right (degrees) recorded during the FRT, 
measured by a CROM device 
• Examiner interpretation of the FRT (positive or negative) 
• Subject and headache characteristics including gender, age, history of 
headache, dominant side of headache, anti-migraine medication helps, 
forward bend increases headache, presence of photophobia or phonophobia, 
nausea, neck movement or positions provoke headache, neck symptoms 
precede headache, and headache of pulsating quality. 
 
Reliability of measures 
Previous studies conducted by the author have shown excellent inter-tester 
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and intra-tester reliability of FRT measurements, when the test is followed by an 
immediate re-test, for both asymptomatic subjects, and subjects with CGH (Hall and 
Robinson 2004; Ogince et al 2007). The examiners in these previous studies were 
also used for the current study. 
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4.5 STUDY 1 
 
Study 1 is encapsulated in the following publication. 
Hall T, Briffa K, Hopper D, Robinson K. 2010 Long-term stability and minimal 
detectable change of the cervical flexion-rotation test. Journal of Orthopaedic and 
Sports Physical Therapy. 40(4):225-229. 
Permission to reproduce this paper was sought and subsequently granted by the 
publisher. 
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4.6 STUDY 2 
 
Study 2 is encapsulated in the following publication. 
Hall T, Briffa K, Hopper D, and Robinson K. 2010 Comparative analysis and 
diagnostic accuracy of the cervical flexion rotation test. Journal of Headache and 
Pain. DOI 10.1007/s10194-010-0222-3 
Permission to reproduce this paper was sought and subsequently granted by the 
publisher. 
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4.7 SUMMARY OF FINDINGS FROM PART A 
The preceding two studies have provided new information regarding the FRT 
and its use in CGH diagnosis. Study 1, demonstrated that range of motion measures 
taken during the FRT are stable over a 2-week period in subjects with CGH and 
examiner interpretation of the FRT is highly reliable over the same time period. 
Moreover the MDC that is required to be confident that a real change has occurred to 
the FRT range of motion deficit, rather than measurement error was identified.  
In Study 2, range of motion deficits during the FRT were significantly larger 
in subjects with CGH when compared with subjects with migraine or MHF. 
Furthermore the FRT showed good sensitivity and specificity in the diagnosis of 
CGH. Collectively the findings from Study 1 and 2 provide further evidence 
supporting the diagnostic utility and long term-stability of the FRT.  
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 Chapter 5: Part B 
Study 3 and 4 
• Validity of the flexion-rotation test 
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5.1 RESEARCH QUESTIONS 
From the preceding studies it can be seen that the FRT has the ability to 
identify individuals with CGH. However it is not clear why range of motion recorded 
during the FRT is reduced in people with CGH. Previously it has been suggested that 
the FRT is selective to the upper cervical spine, specifically the C1/2 motion segment 
(Stratton and Bryan 1994; Dvorak 1998). However the validity of this assumption 
has not been tested. Specifically no studies have measured segmental movement in 
the cervical spine during the FRT. 
Hence the following research questions were developed for Study 3: 
1) What is the range of rotation, at each cervical motion segment, during the 
FRT and during axial rotation? 
2) What proportion of total cervical rotation occurs at C1/2, during the FRT? 
3) What proportion of rotation at motion segments above C4 occurs at C1/2? 
 
5.2 STUDY 3 OBJECTIVES 
The objective of this study was to investigate the validity of the FRT by 
measuring and comparing total and segmental rotation from the occiput to the C4 
vertebra with the neck in neutral position and in flexion position, using magnetic 
resonance imaging (MRI). 
An alternative means of identifying the validity of the FRT as a selective 
measure of C1/2 movement is to measure how pain arising from cervical motion 
segments other than C1/2 influences range of motion recorded during the test. If the 
biomechanical theory regarding the relative isolation of the FRT to the C1/2 segment 
is correct, then pain arising from or dysfunction of motion segments other than C1/2 
should have little influence on range of motion recorded during the FRT. If the FRT 
were to be influenced by the presence of lower cervical facet pain then the validity, 
sensitivity and specificity of the FRT would be diminished. 
Hence the following research questions were developed for Study 4: 
1. Is range of motion recorded during the FRT and examiner interpretation of the 
test influenced by the presence of lower cervical facet joint pain?  
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2. What is the diagnostic accuracy of the FRT in identifying subjects with CGH 
from those with lower cervical facet joint pain? 
 
5.3 STUDY 4 OBJECTIVES 
The objectives of this study were to investigate the impact of lower cervical 
facet pain on range of motion recorded during, and examiner interpretation of the 
FRT. 
 
5.4 METHODOLOGY FOR STUDY 3  
 
5.4.1 Study design Study 3 
A cross-sectional measurement study design was used to investigate the 
validity of the FRT as a test of predominantly C1/2 motion. A comparison was made 
between total and segmental rotation from the occiput to the C4 vertebra with the 
neck in neutral position and in flexion position, using MRI. 
 
5.4.2 Subjects 
Subjects were volunteers recruited from staff at Sapporo Medical University, 
Sapporo, Japan.  
 
5.4.2.1 Inclusion criteria 
Subjects were included if they were less than 145cm tall (to enable 
positioning in the MRI unit), without any history of significant cervical spine or 
shoulder girdle disorders.  
 
5.4.2.2 Exclusion criteria 
Subjects were excluded if they could not achieve end range flexion in the 
MRI unit (22 subjects were excluded in this way). Additionally subjects were 
excluded if they had any evidence on MRI of musculoskeletal disorders of the 
cervical spine. Two orthopedic surgeons experienced in MRI evaluations, inspected 
all MRI images for abnormalities on the sagittal T2-weighted images and the axial 
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T2*-weighted images. Four subjects were found to have potential evidence of 
musculoskeletal disorders (non-symptomatic disc bulging) and were thus excluded. 
All participants were given a written information sheet explaining the 
procedure prior to testing and gave written consent. Approval for this study was 
granted by the Society of Physical Therapy Science in Japan.  
 
5.4.3 Variables 
Independent variables 
• Cervical position - neutral and end range flexion. 
 
Dependent variables 
• Segmental rotation angles combined to the left and the right (Occiput-C1, 
C1-C2, C2-C3, C3-C4 and combined segments below C4). 
• Angle of cervical flexion. 
 
Reliability of measures 
To determine intra-observer variation of the measurement of the segmental 
rotation angles and the angles of neck flexion in both conditions (flexion and end 
range flexion), one investigator measured the images twice on two separate 
occasions. On the second occasion, the examiner was blind to the results of the first 
measurement session. To study inter-observer variation, two different examiners, 
blind to each other’s assessment, measured the same series. 
 
5.5 METHODOLOGY FOR STUDY 4 
 
5.5.1 Study design Study 4 
A single blind between group design was used to investigate whether lower 
cervical joint pain, confirmed by facet joint block, influences FRT mobility and 
examiner interpretation of the test. 
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5.5.2 Sample size calculation  
Sample size estimate was based on data collected from a previous report 
(Ogince et al 2007) and pilot data. A priori power analysis determined that a total 
sample size of 24 subjects (12 in each group) was required to obtain a statistical 
power of 0.80 with alpha set at 0.05. This was based on a single measurement of the 
FRT, together with a known mean value of 27˚ (SD = 11) for the FRT in subjects 
with CGH, with a mean value of 41˚ (SD = 5.1) for the lower cervical facet joint pain 
group. 
 
5.5.3 Subjects 
Recruitment for subjects was as follows: Subjects with CGH were recruited in 
a manner of convenience through advertisements placed in local newspapers and 
through the University website. Subjects awaiting lower cervical facet joint block 
were recruited from private physiotherapy clinics. 
 
5.5.3.1 Inclusion criteria 
CGH - Inclusion criteria for this group were based on criteria developed by 
the IHS (Classification Committee of the International Headache Society 
2004) and Sjaastad (1998), with the exception of diagnostic anaesthetic 
blocks. These criteria include side dominant headache without side shift, 
headache preceded by neck pain, headache precipitated or aggravated by neck 
movement or posture and associated neck, shoulder or arm symptoms. 
Additionally, headache frequency was at least once per week and episodic 
headache occurred for more than the previous 3 months.  
 
Lower cervical facet joint block – Inclusion criteria for this group included 
episodic or continuous neck pain for more for than 3 months and complete, 
even if temporary, pain relief from therapeutic cervical facet joint intervention 
at cervical segments other than at C1/2. Intervention consisted of cervical 
facet intraarticular injections, or cervical medial branch block or cervical 
radiofrequency neurotomy.  
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5.5.3.2 Exclusion criteria 
CGH – Subjects were excluded if their headaches were not of cervical origin 
(Classification Committee of the International Headache Society 2004) and if 
they were unable to tolerate the FRT.  
 
Lower cervical facet joint block – Subjects were excluded if they had CGH, 
arm symptoms, and inability to tolerate the FRT procedure. Subjects thus 
selected were believed to have neck pain arising from lower cervical motion 
segments.  
 
All participants were given a written information sheet explaining the 
procedure prior to testing and gave written consent. The Human Research Ethics 
Committee of Curtin University of Technology granted approval for this study. 
Subject information sheets, consent forms, and ethical approval documentation are 
presented in the appendix section (Chapter 10). 
 
5.5.4 Variables 
 
Independent variables 
• Two groups – CGH and lower cervical facet joint pain 
 
Dependent variables 
• Range of rotation to the left and the right (degrees) recorded during the FRT 
measured by a modified cervical range of motion device (CROM) 
• Examiner interpretation of the FRT (positive or negative side recorded) 
 
Reliability of measures 
Previous studies conducted by the author have shown excellent inter-tester 
and intra-tester reliability of FRT measurements, when the test is followed by an 
immediate re-test, for both asymptomatic subjects, and subjects with CGH (Hall and 
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Robinson 2004; Ogince et al 2007). The examiner used in these studies was also 
used for the current study. 
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5.6 STUDY 3 
 
Study 3 is encapsulated in the following publication. 
Takasaki H, Hall T, Oshiro S, Kenoko S, Ikemoto Y, & Jull G. 2010. Normal 
kinematics of the upper cervical spine during the Flexion-Rotation Test – in vivo 
measurements using Magnetic Resonance Imaging. Manual Therapy 
doi:10.1016/j.math.2010.10.002 
Permission to reproduce this paper was sought and subsequently granted by the 
publisher. 
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5.7 STUDY 4 
 
Study 4 is encapsulated in the following publication. 
Hall T, Briffa K, Hopper D. 2010. The influence of lower cervical joint pain on 
range of motion and interpretation of the FRT. Journal of Manual & Manipulative 
Therapy. 18(3). 126-131. 
Permission to reproduce this paper was sought and subsequently granted by the 
publisher. 
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5.8 SUMMARY OF FINDINGS FROM PART B 
The preceding two studies have provided new information regarding the 
validity of the FRT. Study 3, demonstrated that rotation during the FRT occurs 
primarily at the C1/2 segment. Minimal movement occurred at all other segments 
capable of generating headache. Study 4 demonstrated that FRT range of motion 
deficit was significantly greater in subjects with CGH when compared with subjects 
with lower cervical facet joint pain. The presence of neck pain from segments below 
C1/2 did not diminish FRT sensitivity or specificity. 
These data lend support to the FRT as a valid clinical test of the C1/2 
segment. There can be some confidence that the predominant location of the 
restriction is at the C1/2 segment when side-to-side differences of rotation are found 
in the FRT in the clinical assessment of people with cervical spine disorders 
including CGH. 
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 Chapter 6: Part C 
Study 5 and 6 
• Clinical utility of the flexion-rotation test 
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6.1 RESEARCH QUESTIONS 
The preceding two studies have established that the FRT is a valid test of 
dysfunction arising from the C1/2 segment. What is not certain is the frequency with 
which the C1/2 segment is the cause of CGH. The FRT is a more valuable clinical 
test if there is a high frequency of involvement of the C1/2 segment in CGH.  
The gold standard for the identification of symptomatic spinal motion 
segments in spinal pain disorders is double-blind therapeutic block procedures such 
as facet joint injections. However these procedures are not routinely performed in 
clinical practice, particularly in the upper cervical spine, due to the apparent danger 
of inadvertent needle placement in this invasive technique. Hence, in the absence of 
an available gold-standard, manual examination has been employed to identify the 
symptomatic cervical motion segments in CGH (Zito et al 2006). The reliability of 
manual examination in the segments capable of generating CGH has not been clearly 
established.  
Hence the following research questions were developed for Study 5: 
1) What is the reliability of manual examination procedures in identifying 
symptomatic motion segments above C4 in subjects with CGH? 
2) What is the frequency that each or multiple segments above the C4 level 
are the dominant source of pain in subjects with CGH? 
 
6.2 STUDY 5 OBJECTIVES 
The objectives of this study were to investigate the reliability of manual 
examination procedures and frequency that each or multiple segments above the C4 
segment were the dominant source of pain.  
 
6.3 STUDY 6 OBJECTIVES 
The main objective of this study was to investigate the association between 
the presence and severity of CGH symptoms and the impairment in range of motion 
measured during the FRT. A secondary objective was to investigate whether other 
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subjective features of headache are associated with i) FRT mobility and ii) examiner 
interpretation of the FRT. 
 
6.4 METHODOLOGY FOR STUDY 5 AND 6 
6.4.1 Study design Study 5 
A cross-sectional study design was used to investigate the reliability of 
manual examination and the frequency that cervical motion segments above the C4 
level were the predominant source of symptoms in CGH.  
 
6.4.2 Study design Study 6 
An observational study design was used to investigate the relationship 
between the presence and severity of CGH symptoms or associated factors and FRT 
mobility and examiner interpretation of the FRT. 
 
6.4.3 Sample size calculation Study 5 
Sample size estimate for reliability was calculated to be 39 for α level of 0.05, 
power of 0.8, with a null hypothesis for Kappa of 0 (one-tailed test). However, 
previously we found only 3/62 subjects had symptomatic dysfunction at C0/1 or 
C3/4 motion segments in subjects with CGH (Hall et al 2003). Therefore, a sample 
size of 60 subjects was elected, in order to obtain subjects with segmental 
dysfunction at all levels above C4. To reduce the risk of examiner bias, arbitrarily, 
20 asymptomatic subjects without history of CGH or significant neck pain were also 
examined, but not included in data analysis. Hence the total sample was 80 subjects. 
 
6.4.4 Sample size calculation Study 6 
To allow statistical analysis of all characteristics (headache frequency, 
intensity, headache episode duration, photophobia, etc), at least five subjects were 
required per predictor variable. A total of 10 predictors (see below) required a 
sample size of at least 50 subjects with CGH. Subject recruitment ceased once all 
predictor variables contained at least five subjects, which occurred at 72. To reduce 
examiner bias, arbitrarily an additional 20 subjects who had no significant history of 
Chapter 6 – The Studies Part C 
 105 
neck pain or CGH and who were of similar age to the subjects with CGH, were 
included in the sample. 
 
6.4.5 Subjects 
Recruitment for subjects was as follows: Subjects with CGH were recruited in 
a manner of convenience through advertisements placed in local newspapers and 
through the University website. Asymptomatic subjects were volunteers recruited 
from Curtin University students.  
 
6.4.5.1 Inclusion criteria 
CGH - Subjects were selected based on criteria developed by the IHS 
(Classification Committee of the International Headache Society 2004) and 
Sjaastad (1998). These included a primary complaint of side dominant 
headache without side shift, headache preceded by neck pain, and headache 
precipitated or aggravated by neck movement or posture. Additionally 
headache frequency needed to be at least once per week and episodic 
headaches needed to have been present for more than the previous 3 months.  
Asymptomatic - Asymptomatic subjects were selected based on the absence of 
significant neck pain or CGH.  
 
6.4.5.2 Exclusion criteria 
Subjects were excluded in either Study 5 or 6 if they had inability to 
communicate, inability to tolerate the FRT, if they were receiving physical treatment 
for their neck (for example physiotherapy or chiropractic), and if they did not 
provide informed consent. 
CGH – Subjects with CGH were excluded if they had continuous headache 
for more than 48 hours and headache was not of cervical origin. In addition, 
in Study 5, subjects were excluded if they could not tolerate manual 
examination of the cervical spine. 
 
Asymptomatic - Subjects were excluded if they had significant history of neck 
pain or headache (once per month or more). 
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All participants were given a written information sheet explaining the 
procedure prior to testing and gave written consent. The Human Research Ethics 
Committee of Curtin University of Technology granted approval for this study. 
Subject information sheets, consent forms, and ethical approval documentation are 
presented in the appendix section (Chapter 10). 
 
6.4.6 Variables 
 
6.4.6.1 Study 5 
Independent variables 
• Two examiners 
 
Dependent variables 
Dependent variables were determined by manual examination 
• Symptomatic cervical motion segment (levels C0/1, C1/2, C2/3, and C3/4) 
• Dominant symptomatic cervical motion segment (levels C0/1, C1/2, C2/3, 
or C3/4) 
• Single or multilevel symptomatic motion segment  
• Examiner agreed frequency of single or multilevel symptomatic motion 
segment 
• Examiner agreed frequency of symptomatic cervical motion segment (levels 
C0/1, C1/2, C2/3, and C3/4). 
 
6.4.6.2 Study 6 
Independent variables 
• Two groups - CGH and asymptomatic 
• Headache at the time of test occasion 
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Dependent variables 
• Range of rotation to the most restricted side (degrees) recorded during the 
FRT measured by a modified cervical range of motion device (CROM) 
• Examiner interpretation of the FRT (positive or negative) 
• Subject and headache characteristics including headache duration, intensity 
and frequency as well as gender, age, history of headache, dominant side of 
headache, unilateral nature of headache, presence of photophobia, 
phonophobia, nausea or headache of pulsating quality. 
 
Reliability of measures 
Previous studies conducted by the author have shown excellent inter-tester 
and intra-tester reliability of FRT measurements, when the test is followed by an 
immediate re-test, for both asymptomatic subjects, and subjects with CGH (Hall and 
Robinson 2004; Ogince et al 2007). The examiner in Study 6 was also used for the 
current study. 
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6.5 STUDY 5 
 
Study 5 is encapsulated in the following publication. 
Hall T, Briffa K, Hopper D, & Robinson K. 2010. Reliability of manual examination 
and frequency of symptomatic cervical motion segment dysfunction in cervicogenic 
headache. Manual Therapy. 2010. doi:10.1016/j.math.2010.06.002 
Permission to reproduce this paper was sought and subsequently granted by the 
publisher. 
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6.6 STUDY 6 
 
Study 6 is encapsulated in the following publication. 
Hall T, Briffa K, Hopper D, & Robinson K. 2010. The relationship between 
cervicogenic headache and impairment determined by the cervical flexion-rotation 
test. Journal of Manipulative and Physiological Therapeutics. 
doi:10.1016/j.jmpt.2010.09.002 
Permission to reproduce this paper was sought and subsequently granted by the 
publisher. 
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Summary of findings from part C 
 
The studies undertaken in Part C have provided additional information 
regarding the clinical utility of the FRT. In Study 5, manual examination of the 
cervical spine was found to be reliable when used by two experienced examiners in 
subjects with CGH. Examiners’ rating of manual examination identified the C1/2 
segment as the most common symptomatic segment, with 63% of cases positive at 
this segment. The high frequency of C1/2 segmental involvement in CGH highlights 
the importance of the FRT in CGH evaluation and also highlights the importance of 
specific treatment procedures for this motion segment.  
In Study 6, subjects with CGH demonstrated an inverse relationship between 
an index of headache severity and range of motion measures taken during the FRT. 
Furthermore, headache frequency, intensity and duration were the most significant 
predictors of range of motion measured by the FRT. Although the presence of 
headache during testing significantly reduces range during the FRT by six degrees, it 
does not influence identification of a positive test. It does however suggest caution is 
warranted when using the FRT as a treatment outcome measure.  
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7.1 INTRODUCTION 
 
CGH is a sub-category of secondary headache believed to arise from 
convergence of nociceptive input from the upper three cervical nerve roots with 
trigeminal afferents in the TCN (Bogduk and Govind 2009). Diagnostic criteria for 
CGH have been established but many of the subjective features of CGH are common 
to other headache forms, in particular migraine without aura (Yi et al 2005). 
Consequently incorrect headache diagnosis frequently occurs when relying on 
subjective features for classification (Pfaffenrath and Kaube 1990; Moeller et al 
2008). Aspects of cervical physical examination have been shown to be very useful 
in classifying CGH including manual examination (Amiri et al 2007; Jull et al 2007). 
One form of manual examination, the FRT, is used to identify specific cervical spine 
dysfunction and as an outcome measure following physical intervention (Hall et al 
2007).  
A number of studies have provided some preliminary evidence of the 
potential for the FRT to aid in CGH diagnosis (Hall and Robinson 2004; Hall et al 
2007; Ogince et al 2007; Smith et al 2007; Hall et al 2008). The studies that make up 
this doctoral thesis built on this evidence and establish a number of facts. Part A was 
developed to improve the understanding of the long-term stability, minimal 
detectable change, and diagnostic accuracy of the FRT in CGH evaluation. Part B 
established the validity of the FRT as a test of cervical movement impairment at, and 
pain arising from, the C1/2 level. Part C of this research added to the understandings 
of the relationship between impairment identified by the FRT and headache 
symptoms, providing more useful evidence of the clinical utility of the FRT in CGH 
evaluation. 
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This chapter will present a discussion of the findings of the six studies 
reported in relation to the relevant literature. Limitations of the research are outlined 
and recommendations for future research made. Finally the clinical implications of 
this research are considered. 
 
7.2 PART A – RELIABILITY AND DIAGNOSTIC ACCURACY 
OF THE FRT 
Headache symptoms are usually evaluated by monitoring the frequency, 
intensity and duration of headache attacks over days or weeks (Andrasik et al 2005). 
Indeed, the frequency of headache attack was nominated as the most important 
indicator of treatment success in a survey of people attending physiotherapy private 
practice for management of headache (Niere and Robinson 1997). Headache attack 
frequency in people with CGH is usually intermittent, becoming more constant with 
chronicity (Sjaastad and Bakketeig 2007). In a large survey of a small town in 
Norway, the most common attack frequency was one headache per two- to four-
weeks (Sjaastad and Bakketeig 2007), indicating a large gap between headache 
events. Thus to monitor change in headache as a result of management, evaluation of 
people who suffer with CGH usually entails assessment of headache episodes over 
prolonged periods of time, usually weeks rather than days. It is therefore very 
important that measurements taken to measure clinical features of CGH are stable 
over time. This is necessary to be sure that alteration in assessment parameters are 
related to the specific intervention rather than random fluctuation in the measurement 
tool. Normal values for range of movement measured during the FRT in 
asymptomatic subjects and for subjects with CGH have been established (Hall and 
Robinson 2004). In addition the FRT has been shown to be a reliable measure of 
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cervical movement impairment on a test and re-test basis (Hall and Robinson 2004; 
Ogince et al 2007). The stability of the measurement over time, however, has not 
been tested. In addition the magnitude of error, or MDC, between repeated trials of 
the test is unknown.  
To our knowledge Study 1 is the first to identify the long-term stability of the 
FRT over weeks, and the MDC in both asymptomatic and symptomatic people. 
A previous study has shown that the FRT has excellent sensitivity, specificity 
and examiner agreement in the diagnosis of CGH in highly controlled homogenous 
samples (Ogince et al 2007). In that study subjects were carefully selected. 
Comparison groups were strictly defined single headache forms (migraine with aura 
and asymptomatic control), without cervical spine dysfunction. Such careful 
selection of subjects for comparative groups may have artificially inflated the 
diagnostic accuracy of the FRT in CGH diagnosis.  
Individuals who suffer from headache frequently present with a range of 
different headache features, sometimes manifesting with more than one headache 
form. This fact is supported by various investigations of large cohorts of people who 
suffer with chronic headache suggesting that many individuals report more than one 
form of headache (Pfaffenrath and Kaube 1990; Fishbain et al 2001; Amiri et al 
2007). In a survey of the population of the town of Vaga in Norway 41/75 people 
diagnosed with CGH were found to have one headache form. The remaining 34 were 
found to have CGH together with other headache forms (typically TTH or migraine) 
(Sjaastad and Bakketeig 2007). Classification of headache is thus complicated by the 
presence of more than one headache form in any individual sufferer of headache.  
As each headache form arises from differing underlying pathophysiological 
processes, management for each condition must vary accordingly. For example CGH 
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is known to respond to manipulative therapy (Jull et al 2002). However, a systematic 
review indicated that people who suffer from migraine or TTH do not respond to 
such forms of treatment (Bronfort et al 2004). Hence, the identification of CGH is 
important to physiotherapists and other practitioners of manipulative therapy, as it 
informs the practitioner of the potential for physical treatment.   
The FRT may aid in the identification of CGH, but knowledge of the 
responsiveness of the FRT in differentiating CGH from migraine without aura, or 
MHF is not known. To our knowledge Study 2 is the first to identify the diagnostic 
accuracy of the FRT in identifying subjects with CGH from those with migraine 
without aura, or those with MHF. 
 
7.2.1 Study 1 (Chapter 4.5) 
The aims of this study were to identify the long-term stability of the FRT 
measurements, to investigate the long-term reliability of test interpretation, and to 
establish the MDC for FRT measurements. Fifteen subjects with chronic CGH were 
assessed using the FRT on four occasions. These occasions were spread over two-
weeks and conducted by an experienced examiner. An additional 10 asymptomatic 
subjects were included to reduce examiner bias, but were not included in the 
analysis. The examiner was blind to the subject’s symptomatic status. For subjects 
with CGH there was no significant change in FRT range of motion over days. 
Intratester reliability for range recorded during the FRT was excellent for right and 
left rotation. Furthermore examiner interpretation of the FRT was almost perfect 
according to the Landis and Koch scale (Landis and Koch 1977).  
The results for Study 1, demonstrate that measurement of range recorded 
during the FRT is reliable and stable over time when assessed by a single 
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experienced examiner. Furthermore examiner interpretation of the test is consistent 
over time. These results are in keeping with previous findings of high levels of inter-
and intra-therapist reliability for the FRT (Hall and Robinson 2004).  
Stability for other range of motion measures of the cervical spine have also 
been investigated over a one-week time period and were found to be less consistent 
than that found for the FRT (Sterling et al 2002). In the present study SEM’s of two 
degrees and three degrees for right and left rotation respectively were recorded. This 
is consistent with previous studies of the FRT (Hall and Robinson 2004), but at the 
lower end of the range shown for studies of active cervical range of motion 
(Pellechia and Bohannon 1998; Petersen et al 2000; Fletcher and Bandy 2008). 
Lower levels of error for the FRT when compared with whole cervical range of 
motion testing may be due to the fact that the FRT is a passive procedure in contrast 
to cervical range of motion testing, which is active. Passive movement testing may 
reduce the potential for error. 
These results show that the minimal detectable change for FRT range of 
motion data was 4.7˚ for right rotation and seven degrees for left rotation. In 
addition, the standard error of measurement was less than three degrees. Minimal 
detectable change values indicate that a change in FRT range of motion of at least 
seven degrees is required to be 90% confident that a change has occurred rather than 
measurement error. Previously a 10˚ difference has been estimated as a clinically 
meaningful difference in range of motion for a positive FRT. The MDC of seven 
degrees found in this study indicates that a 10˚ difference in range for a positive FRT 
is greater than the error-free threshold.  
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7.2.2 Study 2 (Chapter 4.6)  
The aim of this study was to compare the findings of the FRT between 
subjects with CGH, migraine without aura, and MHF. An additional aim was to 
identify the diagnostic accuracy of the FRT in CGH evaluation, and to determine the 
most significant predictors of range of motion during the FRT. Sixty subjects with 
chronic headache (20 with CGH, 20 with migraine without aura and 20 with MHF) 
were evaluated by a single experienced examiner using the FRT on a single 
headache-free occasion. The examiner was blind to the subject’s group allocation.  
The results indicted that the average range of unilateral rotation to the most 
restricted side during the FRT was least in subjects with CGH and most in subjects 
with migraine. Range was significantly reduced in the CGH group when compared 
with the other two groups, with an additional smaller significant difference being 
noted between the migraine and MHF. Based on the FRT, an experienced examiner 
was able to make the correct diagnosis of CGH 85% of the time. Furthermore it was 
determined that a range of 30˚on the FRT can be considered to be the cut-off point 
for a positive test.  
This is the first study to compare FRT range of motion deficits in subjects 
with CGH, migraine, and MHF, hence no direct comparisons can be made with other 
research. Mean range in subjects with CGH was consistent with previous reports 
(Hall et al 2008; Hall et al 2010). In addition mean range in subjects with migraine 
without aura was consistent with previous reports for migraine with aura (Ogince et 
al 2007) and only marginally less than asymptomatic controls (Hall and Robinson 
2004; Smith et al 2007).  
The FRT evaluates range of motion predominantly in the upper cervical spine. 
Other studies have investigated cervical active range of motion deficits in subjects 
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with CGH, TTH and migraine. Some studies (Zwart 1997; Zito et al 2006; Jull et al 
2007) but not all (Dumas et al 2001; Hall and Robinson 2004) have reported 
diminished cervical range of motion in subjects with CGH when compared with 
asymptomatic subjects. Limitation of active movement in the sagittal plane is the 
major movement loss. Similar deficits in cervical range of motion have been reported 
in people who suffer from TTH (Fernandez-de-las-Penas et al 2006) and migraine 
(Fernandez-de-Las-Penas et al 2006; Bevilaqua-Grossi et al 2009), although not for 
all movements. In contrast, other studies have failed to find evidence of cervical 
range of motion deficits in people who suffer from migraine (Kidd and Nelson 1993; 
Dumas et al 2001; Zwart and Sand 2002; Fernandez-de-Las-Penas et al 2006; Zito et 
al 2006).  
One explanation for the inconsistency in reported studies of cervical 
movement deficits in migraine may be due to the poor methodological quality of 
studies undertaken. A systematic review of published studies up till April 2006 found 
no convincing evidence of cervical musculoskeletal dysfunction (including cervical 
range of motion) in people with migraine, where evaluated studies were of sound 
methodological quality (Robertson and Morris 2008).  
Other reasons for discrepancy between published studies regarding range of 
motion deficits in headache may be the small sample sizes and differences in subject 
profiles in the evaluated studies. For example the study by Bevilaqua-Grossi et al 
(2009) had a small sample size and was considered a pilot study. Furthermore 
cervical mobility was only reduced by a mean eight degrees in right rotation in those 
with migraine. Further differences in range of motion were found between people 
with transformed migraine and episodic migraine. Furthermore there was no 
association between the side of migraine headache and direction of movement 
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limitation (Bevilaqua-Grossi et al 2009). This is contrary to range of motion deficits 
identified by the FRT, which occur predominantly towards the side of pain. 
Thus for a person presenting to a clinic with headache, associated neck pain 
and minor limitation of cervical range of motion does not necessarily indicate CGH. 
Further physical examination tests are required in that individual to confirm the 
presence of CGH. These findings further highlight the importance of the FRT in 
CGH evaluation.  
The present study indicates a slightly lower cut off value for a positive FRT 
when compared with earlier studies. The current study identified a cut-off score of 
30˚, whereas previously a cut-off score of 32˚ was reported (Hall et al 2008). This 
information has implications for clinical practice where diagnosis of CGH might rely 
on a number of features including the individual’s presenting symptoms as well as 
physical examination findings (Hall et al 2008). As up to 55% of people who suffer 
from headache have more than one headache form (Pfaffenrath and Kaube 1990; 
Fishbain et al 2001; Amiri et al 2007; Sjaastad and Bakketeig 2007; Sjaastad and 
Bakketeig 2007), the identification of CGH is made difficult by the mixture of 
headache characteristics. In individuals who have subjective features that do not fit 
into a specific headache category (or who have evidence of MHF) then the physical 
examination becomes more important. In this case a lower cut-off score is necessary 
on the FRT for the examiner to be confident of a diagnosis of CGH. In individuals 
with a relatively pure form of CGH, clearly defined by the presenting symptoms, 
then a higher cut-off score might be adequate. 
The factors associated with migraine headache in this study were not 
associated with range of motion deficits determined by the FRT. In contrast, almost 
half the variance in FRT range of motion was explained by the presence of two 
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variables potentially indicating cervical spine dysfunction. These were: neck 
movement or positions that provoke headache, and neck symptoms that precede 
headache. These factors provide further evidence for involvement of the cervical 
spine in CGH pathogenesis.   
The results of these studies have allowed a greater understanding of the 
stability, reliability and diagnostic accuracy of the FRT in CGH evaluation. It is 
concluded that the FRT has a low level of error associated with repeated 
measurement and measurements taken are stable over a two-week time period. 
Furthermore, test interpretation is reliable over this time period. Although migraine 
and CGH have differing underlying pathophysiological mechanisms, they typically 
present difficulty in differential diagnosis. These results indicate that the FRT can aid 
in the differential diagnosis of CGH, even when an individual may present with 
MHF.  
 
7.2.3 Limitations 
There are several limitations to these two studies, some of which have 
previously been discussed in Chapters 4.5 and 4.6. It must be noted that the FRT 
predominantly evaluates movement impairment at the C1/2 motion segment, and 
may not adequately test other motion segments or other structures capable of causing 
CGH. This might explain why six of the 20 subjects with CGH tested negative on the 
FRT in Study 2. Clinically a negative FRT does not indicate that the individual being 
tested does not have CGH. Rather the symptomatic cervical motion segment may be 
C0/1, C2/3 or C3/4. Alternatively pain may arise from myofascial structures (Borg-
Stein 2002), or sensitized neural structures (Jull 1997), although such involvement is 
relatively rare (Zito et al 2006). Hence, the FRT is not the only assessment that 
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should be carried out on individuals suspected of having CGH. Other tests include 
cervical spine range of motion in the cardinal planes, manual examination of the 
upper cervical segmental levels above the C4 vertebra, and craniocervical muscle 
function (Hall et al2008; Jull et al 2007; Zito et al 2006). 
A further limitation was the inability to fully comply with published 
guidelines for the classification of CGH (Sjaastad et al 1998) as it was not possible to 
include cervical spine diagnostic blockade in the identification of CGH. Diagnostic 
block procedures of the upper cervical spine are not performed routinely by medical 
practitioners in Perth. Hence subjects in the study could only be characterized as 
having “probable” CGH, as they fulfilled only five out of seven diagnostic criteria 
for CGH (Antonaci et al 2001). It is possible that subjects with other headache forms 
were misclassified and included in Group CGH, thus impairing calculation of the 
diagnostic accuracy of the FRT in CGH evaluation. If this were the case then the 
diagnostic accuracy of the FRT is likely to be higher than calculated in Study 2.  
Finally the sample size calculation for Study 2 was performed for a difference 
between groups, when in fact this calculation should have been calculated using the 
sensitivity of the FRT to identify CGH (Flahault et al 2005). With a sensitivity of 
70% and a lower confidence limit of 0.7 the sample size is 248 (Flahault et al 2005). 
This indicates that Study 2 was probably underpowered. 
 
7.2.4 Directions for future research 
Study 1 only investigated intra-therapist reliability over days and weeks. 
Future studies should investigate inter-therapist reliability over a similar time frame. 
In addition the minimal clinically important difference for range of motion measured 
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during the FRT should also be calculated for subjects with CGH and those with MHF 
including CGH. 
Study 2 only investigated migraine without aura. A previous study has 
investigated migraine with aura (Ogince et al 2007). Future studies should 
investigate the FRT in other headache forms such as TTH. Furthermore, future 
studies should also investigate the diagnostic accuracy of the FRT with the 
comparison group consisting purely of migraine without aura.  
  
7.3 PART B  - VALIDITY OF THE FLEXION-ROTATION TEST 
 
7.3.1 Study 3 (Chapter 5.6) 
The aim of this study was to investigate the validity of the FRT by measuring 
and comparing total and segmental rotation from the occiput to the C4 vertebra with 
the neck in neutral position and in flexion. Magnetic Resonance Imaging (MRI) was 
used to evaluate 19 asymptomatic subjects, without significant history of neck pain 
or cervical spine disorders. The angle of rotation was assessed at each vertebral level  
(Occiput –C4) with the head maximally rotated to the left and right under two 
conditions – neck in neutral (axial rotation) and in flexion (FRT).  
The results indicate that there was a significant difference in the pattern of 
cervical segmental rotation between axial rotation and the FRT. At the C0/1 segment, 
there was negligible range recorded either in a neutral or flexed position. In contrast, 
the most mobile segment was C1/2, providing three quarters of the total rotation 
during the FRT. At the C1/2 segment, there was a 16.3% reduction in range of 
rotation in the flexed compared with the neutral position. This was minimal when 
compared with the reduction that occurred at the other cervical segments: 68.1% at 
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C2-C3, 61.4% at C3-C4 and 76.9% collectively at the cervical segments distal to C4.  
These findings lend support to the validity of the FRT as an assessment of movement 
predominantly at the C1/2 segment (Dvorak and Dvorak 1990).  
To our knowledge this is the first study to measure segmental movement 
during the FRT. MRI is a highly accurate means of measuring segmental motion that 
has been used extensively in other kinematic studies of the cervical spine (Miyazaki 
et al 2008; Miyazaki et al 2008; Morishita et al 2008; Morishita et al 2008; Daffner 
et al 2009; Morishita et al 2009; Takasaki et al 2009). This level of accuracy was 
reflected in the high levels of intra-observer reliability in the present study. Intra-
class correlation coefficients were greater than 0.7 and the largest standard error of 
measurement was 0.4˚. Hence the recorded ranges can be interpreted with a 
reasonable level of confidence.  
It was apparent that flexing the cervical spine had a much greater impact on 
reducing movement at segments distal to C1/2. Not withstanding this, the C1/2 
segment had 16% less rotation in end range flexion when compared with neutral. 
This may be explained partly by the difficulty in holding the head and neck in end 
range flexion in the MRI scanner during the data acquisition process. In the present 
study a specifically designed piece of apparatus was used to fit in the scanner to hold 
the neck in flexion with an assistant’s help. However, this may not have been as 
effective as manually holding the neck in flexion. Clinical experience reinforces the 
importance of maintaining full range flexion when performing the FRT. Failure to do 
so usually leads to a larger range of rotation than the reported normal range of 44˚ 
(Hall and Robinson 2004). Inexperienced examiners record a larger range of rotation 
than experienced examiners for this reason (Hall et al 2007). Hence, the 12% change 
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in rotation range between neutral and end-range flexion at the C1/2 segment may 
simply reflect inability to maintain maximal flexion of the neck during rotation.  
Another explanation for the small reduction in rotation range at the C1/2 
segment during the FRT may be due to changes in tension of the alar ligaments and 
tectorial membrane. These ligaments limit axial rotation at this segment (Crisco et al 
1991) and are under greater tension in flexion when compared with neutral (Panjabi 
et al 1991).  
Although this is the first study to measure segmental movement during the 
FRT, other studies have reported range of motion of the whole neck (Walmsley et al 
1996; Amiri et al 2003; Hall and Robinson 2004; Ogince et al 2007; Smith et al 
2007; Hall et al 2008). In each case external measurement devices have been 
employed. However, the reported ranges are generally consistent. In the present 
study range was recorded as 89°. Walmsley et al (1996) and Amiri et al (2003) used 
an external electromagnetic device, the 3Space Tracker system, and reported ranges 
of 101˚ and 81° respectively for total head rotation in the FRT position. Hall et al 
(2008) used a Cervical Range of Motion goniometer and recorded 89° for total head 
rotation in the FRT position. Small variation in range between these studies may 
relate to different test procedures. For example Amiri et al performed the FRT in 
sitting (Amiri et al 2003). In this study the subjects were examined in supine.  
Only the upper four cervical segments are capable of causing CGH (Bogduk 
and Govind 2009). This study recorded a combined range of 65˚ rotation at the C1/2 
segment during the FRT. When considered as a percentage of the total rotation range 
available at cervical segments capable of causing headache, this accounts for 
approximately 90% of the range. This attests to the importance of the C1/2 segment 
in CGH pathogenesis. According to these results, any individual presenting with a 
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large deficit of rotation identified by the FRT must have movement impairment of 
the C1/2 segment. This segment is therefore likely to be a contributing factor to the 
CGH pathogenesis in that individual.  
 
7.3.2 Study 4 (Chapter 5.7) 
The aim of this study was to investigate the impact of lower cervical facet 
joint pain on range of motion recorded during the FRT, and examiner interpretation 
of the FRT. Twenty-four subjects were evaluated, 12 with CGH and 12 with lower 
cervical facet joint pain confirmed by therapeutic cervical facet joint intervention. A 
single blinded experienced examiner conducted the FRT. The examiner reported the 
test state (positive or negative) before measuring range of motion. Subjects with 
lower cervical facet pain were evaluated prior to therapeutic block intervention and 
were excluded from analysis if they did not gain complete symptomatic relief 
following the block procedure. Only subjects with immediate complete relief were 
included.  
The average range of unilateral rotation to the limited side during the FRT 
was significantly less in the CGH group compared with the lower cervical facet pain 
group. There have been no previous reports of range of motion data for the FRT in 
subjects with lower cervical facet joint pain. In addition this is the first study to 
compare FRT range of motion data in subjects with CGH and subjects with lower 
cervical facet joint pain. Range of motion in subjects with CGH was consistent with 
previous studies (Hall et al 2008; Hall et al 2010). In contrast, range was 
significantly greater, by 12˚ , in subjects with lower cervical facet joint pain.  
Despite the block procedure confirming a lower cervical segment as the 
source of pain, mean range of motion on the FRT was 38˚. This is slightly less than 
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the previously reported normal range of 45˚ (Hall and Robinson 2004; Smith et al 
2007). This small deficit in range may be explained by a number of possible 
processes. It has been shown that the presence of headache at the time of testing 
significantly reduces the measured range recorded during the FRT by an average of 
six degrees (Hall et al 2010). In contrast, in subjects with migraine, active cervical 
range of motion was not influenced by the presence of headache at the time of 
testing, according to one study (Bevilaqua-Grossi et al 2009). Whether subjects with 
lower cervical facet pain had neck pain during the test procedure was not recorded. 
However, it is possible that neck pain induces changes in neck muscle tone, thereby 
influencing muscle extensibility and cervical range of motion.  
An alternative explanation for the reduced range of rotation in subjects with 
lower cervical facet pain may be that symptomatic cervical segments were 
hypomobile and could not contribute towards rotation during the FRT as they would 
normally. In Study 3 it was demonstrated that approximately 25% of the rotation 
recorded during the FRT arises from cervical segments below C1/2. Hence 
impairment in range of motion at symptomatic segments may adequately explain the 
shortfall of six degrees found in subjects with lower cervical facet pain.  
One further explanation for the reduced range of rotation in subjects with 
lower cervical facet pain may be explained by the presence of sub-clinical upper 
cervical joint dysfunction that was not sufficient to cause CGH. The presence of sub-
clinical pain has previously been shown to influence range recorded during the FRT 
by eight degrees (Smith et al 2007), similar to the range recorded in subjects with 
lower cervical facet pain. The presence of sub-clinical neck pain has also been shown 
to influence cervical active range of movement (Lee et al 2004). 
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Study 4 found high levels of diagnostic accuracy for the FRT. Based on the 
examiner’s interpretation of this test, sensitivity and specificity for CGH diagnosis 
was 75% and 92% respectively. An experienced examiner was able to make the 
correct diagnosis 90% of the time using the FRT. Furthermore it was determined that 
a range of 32˚on the FRT can be considered to be the cut-off point for a positive test. 
Despite the deficit in range of rotation in subjects with lower cervical facet 
pain, only one of 12 subjects were classified as having a positive FRT in this group. 
In contrast, nine of 12 subjects with CGH were classified positive on the FRT. The 
high level of diagnostic accuracy may be explained by the “eye-balled” 10˚ estimated 
limitation of range for a positive test.  Only one subject was deemed to have a FRT 
range of motion deficit of more than this, and hence a positive FRT.  
Previous to these doctoral studies a goniometer determined cut-off score of 
32-33˚ for a positive FRT had been established (Ogince et al 2007; Hall et al 2008). 
These scores were identified in highly selected homogenous samples (CGH, 
migraine with aura, and asymptomatic), which is not normal clinical practice. In 
Study 2 a cut-off point of 30˚ was identified. The sample in Study 2 represents a 
more realistic clinical population. Subjects had migraine without aura, CGH or MHF. 
MHF were included as this is a more common type seen in clinical practice 
(Pfaffenrath and Kaube 1990; Fishbain et al 2001; Amiri et al 2007). For example, a 
survey of 196 people with headache found that 45% had single headache form, of 
which 20% had CGH and 20% migraine (Jull et al 2007). Hence a lower cut-off 
value of 30˚ is preferred in general clinical practice, when using a goniometer. A cut-
off value of 30˚ is also well below the mean range recorded for subjects with lower 
cervical facet pain found in this study. Hence cervical segmental pain and 
dysfunction, arising from segments below the C2 vertebra, should not influence 
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determination of a positive FRT. An examiner can be confident that a positive FRT 
indicates impairment of the C1/2 segment. They need not be aware that the 
individual being examined may also have pain arising from a lower cervical 
segment. 
 
7.3.3 Limitations 
There are several limitations to these studies, some of which have previously 
been discussed in Chapter 5.6 and 5.7. In Study 3 intra-tester and inter-tester 
reliability of the measurement of range of rotation taken from a single digital image 
was evaluated. Ideally, MRI should be performed on two separate occasions, with a 
suitable time-interval to evaluate reliability of the measurement technique. However 
this was not feasible due to the high cost and difficulty in gaining access to the 
imager. Previously a number of studies have employed the method used in Study 3 to 
measure kinematics of the cervical spine (Miyazaki et al 2008; Miyazaki et al 2008; 
Morishita et al 2008; Morishita et al 2008; Daffner et al 2009). In none of these 
studies was reliability reported. Although the accuracy of MRI appears to be 
accepted, further studies are required to confirm the accuracy of segmental cervical 
rotation determined by MRI. 
In Study 4, as previously stated, end-range flexion may not have been 
achieved due to the constraints of the MRI scanner. Failure to achieve end-range 
flexion may have allowed greater movement to occur than would perhaps occur in 
the clinical test. Further studies are required to investigate this. 
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7.3.4 Directions for future research 
Study 3 only investigated cervical segmental rotation during the FRT in 
asymptomatic subjects. Future studies should investigate segmental rotation in 
subjects with CGH and other headache forms. This would provide information 
regarding the validity of the FRT in CGH evaluation. In addition, future studies 
should investigate cervical segmental rotation before and after therapeutic 
intervention. It would be of value to see if range of motion changes with cervical 
spine interventions. Furthermore, it may be useful to understand whether range of 
motion deficits improve as headache symptoms improve. Different interventions 
could be evaluated to see which form of treatment is most effective in reducing C1/2 
segmental movement deficits. 
Studies 3 and 4 sought evidence for the validity of the FRT as an isolated test 
of movement and impairment of the C1/2 segment. This was achieved by 
determining whether lower cervical facet joint pain influenced the FRT. Future 
studies should investigate whether patients with pain and dysfunction arising from 
the C1/2 segment (confirmed by comparative local anaesthetic blocks) have deficits 
on the FRT. Alternatively, subjects with radiologically confirmed congenital fusion 
of the C1/2 segment could be tested to evaluate the specificity of the FRT. 
Biomechanical theory would suggest that a person with a congenital fusion of the 
C1/2 segment should have gross limitation of the FRT. 
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7.4 PART C – CLINICAL UTILITY OF THE FLEXION-
ROTATION TEST 
 
7.4.1 Study 5 (Chapter 6.6) 
The aims of this study were to investigate the frequency with which each or 
multiple segments above the C4 vertebra were the dominant source of symptoms in 
subjects with CGH. In doing so the inter-tester reliability of manual examination 
procedures that were used to identify the symptomatic cervical motion segments was 
first examined. Eighty subjects were evaluated, 60 with CGH and arbitrarily a further 
20 asymptomatic subjects were included to reduce examiner bias. Asymptomatic 
subjects were subsequently omitted from data analysis. Two experienced examiners 
evaluated each subject with standard manual examination procedures. Each examiner 
independently rated each segment above the C4 vertebra for pain and dysfunction. 
The C1/2 segment was found to be the most commonly agreed dominant 
source of symptoms in subjects with CGH. Agreed positive findings at this level 
occurred in 63% of cases. Other segments were less frequently dominant, with 30% 
of cases at C2/3, seven percent at C0/1 and none at C3/4. Where examiners agreed 
on positive cases, a finding of multiple segmental involvement was more common 
than uni-segmental involvement.  
This is the first study to report the frequency with which motion segments in 
the upper cervical region are the dominant symptomatic segment in subjects with 
CGH. However, consistent with these results, the C1/2 segment has been previously 
reported as a common source of CGH (April et al 2002; Hall and Robinson 2004; 
Zito et al 2006). In one of these studies (Zito et al 2006), dysfunction at the C1/2 
segment identified by manual examination was found to be the most important factor 
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for discriminating subjects with CGH from subjects with migraine with aura and 
asymptomatic controls. Other studies have demonstrated the importance of 
anaesthetic block procedures at the C1/2 segment for relief of headache symptoms 
(April et al 2002). Similarly an anaesthetic block procedure of the C2 nerve root, 
arising from the C1/2 segment, was the most important procedure to gain complete 
pain relief of symptoms in a small sample of 14 subjects with CGH (Bovim et al 
1992). These results indicate the importance of the FRT in CGH evaluation.  
Zito et al (2006) performed manual examination in 27 subjects with CGH and 
reported positive findings in 70% at C0/1, 72% at C1/2, 48% at C2/3, and 20% at 
C3/4 segments. In contrast, in the present study only 11 of the 60 subjects showed 
similar findings to those of Zito et al (2006). It is unclear why there was such a big 
difference between these two studies in the frequency of positive findings at C0/1. 
Disparity may relate to differences in sample size or differences in tests of manual 
examination. Zito et al (2006) used palpation techniques described by Maitland 
(2001) to identify positive findings. In contrast the present study used similar 
palpation techniques but in combination with tests of passive physiological inter-
vertebral movement (Maitland et al 2001; Monaghan 2001). Only when results from 
both tests concurred was the cervical segment labeled as positive based on manual 
examination.  
With the findings of these studies in mind, it could be proposed that using a 
combination of test techniques may be a more rigorous means of identifying positive 
segments than relying on palpation alone. It is possible that pain provoked by 
palpation of the cervical spine arises from pressure over tender points in muscles, 
rather than indicating joint impairment per se. Tender points or trigger points are 
reported to be common in people with headache (Jaeger 1989; Leone et al 1998; 
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Marcus et al 1999; Freund and Schwartz 2000; Borg-Stein 2002; Moore 2004; 
Jensen 2005; Fernandez-de-Las-Penas et al 2006; Roth et al 2007). Trigger points in 
the sub-occipital region are also common (Fernandez-de-las-Penas et al 2006). 
Hence the high frequency of positive findings at C0/1 reported by Zito et al (2006) 
may simply be due to tender points in muscle, rather than true articular impairment. 
Further studies would be required to investigate this.  
The only disadvantage to using passive physiological inter-vertebral 
movement techniques is that they require a significant amount of skill on the part of 
the operator. Lack of skill may be one reason why a systematic review found these 
tests to have low levels of reliability, with low levels of internal and external validity 
(van Trijffel et al 2005). Alternative explanations for low levels of reliability may be 
poor methodological quality of the studies rather than poor reliability of the 
examination technique itself (Stochkendahl et al 2006).  
The present results show good levels of inter-tester reliability. This may be 
explained by the fact that examiners were experienced and followed a checklist of 
criteria developed for improving methodological quality of reliability studies (van 
Trijffel et al 2005). Additionally, in contrast to the study reported here, some 
previous reports of reliability of manual examination have not used appropriate 
statistical analysis (Sim and Wright 2005). For example Smedmark et al (2000) 
examined inter-examiner reliability of manual examination tests at the C1/2 segment. 
Although percentage agreement was high, the standard Kappa coefficient was only 
0.28, and the examination procedure was reported as only having fair reliability. In 
that study there were no reports of the bias or prevalence indices, but the presence of 
the attribute, in this case a positive finding at the C1/2 segment, was very low, 
comprising only three percent of the sample. Based on estimates of raw data, the 
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Prevalence Adjusted Bias Adjusted Kappa coefficient would rise to 0.74, which 
indicates substantial agreement. The findings of good reliability, together with re-
evaluation of previously reported data in the present studies, indicate more favorable 
interpretation of reliability for cervical spine manual examination procedures.  
 
7.4.2 Study 6 (Chapter 6.7) 
The aim of this study was to investigate the association between the presence 
and severity of CGH symptoms and the impairment in range of motion measured 
during the FRT. A secondary aim was to investigate whether other subjective 
features of headache are associated with i) FRT mobility and ii) examiner 
interpretation of the FRT. Ninety-two subjects were evaluated, 72 with CGH and an 
additional 20 asymptomatic subjects. A single blinded experienced examiner 
conducted the FRT, reporting the test state (positive or negative) before measuring 
range of motion.  
The results revealed that mean range of motion during the FRT was 
significantly reduced by six degrees in the presence of headache at the time of 
testing, but this did not influence the examiner’s interpretation of the test. These data 
indicate that the FRT can be applied and correctly interpreted even in the presence of 
headache. However, the presence or absence of headache at initial and follow-up 
evaluation needs to be taken into consideration when using the FRT as a measure of 
treatment outcome. This would be an additional consideration on top of the minimal 
detectable change of seven degrees, required to be confident that real change has 
occurred rather than measurement error (Hall et al 2010). 
There have been only two previous reports regarding the presence of pain at 
the time of testing on cervical spine range of motion. In one study, episodic or 
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transformed migraine pain at the time of testing did not influence active cervical 
range of motion (Bevilaqua-Grossi et al 2009). Furthermore no correlation was found 
between the range of motion during the FRT and the severity of CGH at the time of 
testing (Ogince et al 2007; Hall et al 2010). Perhaps the presence of pain associated 
with CGH is a more important influence on range of motion than the severity of the 
pain itself. 
Other studies may have indirectly evaluated the effect of pain on range of 
motion testing by comparing inter and intra-tester reliability of repeated 
measurements of cervical range of motion in symptomatic and asymptomatic 
subjects (Sterling et al 2002; Fletcher and Bandy 2008). In both studies there were 
reduced levels of reliability in subjects with neck pain when compared with subjects 
who were asymptomatic. Future studies should investigate the influence of pain at 
the time of testing on range of motion in patients with neck pain. 
Physiotherapists are recommended to assess range of movement when 
examining patients with spinal pain (Maitland 2001). Limitation of movement is 
thought to indirectly measure pain and disability, and is therefore used to measure 
progress in rehabilitation. Such limitation, however, is not always correlated with 
functional disability. For example no evidence was found for a relationship between 
lumbar spine range of motion and functional disability in patients with chronic low 
back pain (Nattrass et al 1999). Similar lack of association between range of motion 
and pain has been reported for middle-aged females with chronic neck pain (Ylinen 
et al 2004). In contrast cervical left rotation and flexion movements were correlated 
with the severity of neck pain in male forestry workers (Hagen et al 1997). Likewise, 
low back pain severity was correlated with lumbar range of motion (Kang et al 
1995).  
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This is the first study to investigate in detail the correlation between headache 
and subject characteristics and range of motion recorded during the FRT. The results 
showed that half the variance in FRT range of motion was explained by an index of 
headache severity, or component parts of this index, headache frequency, intensity, 
and duration. In addition examiner interpretation of the FRT was not influenced by 
other subject or headache characteristics including gender, age, history of headache, 
side of headache, photophobia, phonophobia, associated nausea, and headache of 
pulsating quality. The later four criteria are features of migraine. Thus it can be said 
that range of motion deficits identified by the FRT are not diagnostic features of 
migraine with or without aura (Ogince et al 2007; Hall et al 2010). It would appear 
that the correlation between range of motion and headache symptoms only relates to 
people with CGH. Knowledge that limitation of movement during the FRT is related 
to the severity of headache symptoms provides evidence that the FRT is a useful 
measure of cervical impairment in CGH evaluation. 
 
7.4.3 Limitations 
There are several limitations to these studies, which have previously been 
discussed in detail in Chapters 6.6 and 6.7.  
 
7.4.4 Directions for future research 
Study 5 only investigated reliability of manual examination of cervical 
segments above the C4 vertebra. Future studies of reliability should include the 
whole cervical spine. In addition only specialist musculoskeletal physiotherapists 
were used as examiners. Future studies should investigate the impact of examiner 
experience on reliability of manual examination. Finally as the FRT appears to be 
useful in identifying impairment of the C1/2 segment, other simplified means of 
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manual examination are required to reduce the complexity of manual examination 
procedures at the C0/1, C2/3, and C3/4 segments. 
Study 6 only investigated the impact of headache at the time of testing on 
examiner interpretation, and range of motion measured by the FRT. Future studies 
should investigate the effect of neck pain at the time of testing on these variables. In 
addition the impact of pain at the time of testing on range of motion in patients with 
chronic neck pain would also be worth investigating. 
 
7.4.5 Clinical implications 
Compared with other forms of cervical spine manual examination procedures, 
the FRT is a relatively easy method of assessing movement impairment at the C1/2 
segment. The technique is usually well tolerated when carried out as a single test. In 
contrast, repeated application of the FRT in a single data collection session 
sometimes leads to short-term exacerbation of symptoms. This was the anecdotal 
finding in two investigations where the FRT was repeated at least eight times, as a 
result of repeated trials undertaken by two examiners as part of a reliability study 
(Hall and Robinson 2004; Ogince et al 2007). Experience from testing subjects with 
CGH using a single examiner, without repeated measures indicates no flare-up of 
symptoms following the assessment. Furthermore it is not normal clinical practice to 
repeatedly test the FRT. Hence under normal testing conditions, in routine clinical 
practice, no exacerbation should be anticipated when using the FRT.  
Ease of use of the FRT is demonstrated by the fact that recently qualified 
physiotherapists with little manual therapy experience and with no previous 
experience of using the FRT can quickly learn and apply the test with reasonably 
high level of diagnostic accuracy (Hall et al 2008). Although reported range is 
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greater when carried out by inexperienced examiners, the examiner’s interpretation 
of the test is consistent with highly experienced examiners with specialist 
qualifications.  
In terms of recognizing a positive FRT, a visual “eyeballed” estimate of range 
of motion deficit of more than 10˚ is required. For this purpose no equipment is 
required. However when measuring change in range of motion as a result of an 
intervention, the present research suggests that a goniometer would be a more precise 
method of measurement.  Accurate measurement can be accomplished by using a 
standard compass style goniometer, firmly fixed to the patient’s head with Velcro 
bands. Normal range of motion for the test is 44˚ to each side (Hall and Robinson 
2004). When using a goniometer for measurement, range less than 31˚ indicates a 
positive test. Furthermore change in range of more than seven degrees on 
comparable headache free days is required to be certain that range of motion has 
improved, as a result of the intervention, rather than random error. Additionally the 
fact that range recorded and examiner interpretation of the FRT is stable over time 
indicates that this test is a useful clinical procedure that can be incorporated in 
clinical practice with ease.   
It is important to emphasize that the FRT does not discern all cases of CGH. 
The FRT is a relatively isolated test of movement impairment at the C1/2 motion 
segment. This research indicates that approximately 63% of cases with CGH have 
impairment of the C1/2 segment identified by manual examination. Hence the FRT 
would be useful in identifying these subjects as well as measuring outcome following 
intervention. This figure is born out by the high prevalence of FRT range of motion 
deficits in subjects with CGH reported in an earlier study (Hall and Robinson 2004) 
and in the current research. 
Chapter 8 – Summary & Conclusions 
 155 
It must be recognized that 37% of subjects with CGH did not have a C1/2 
impairment on manual examination. Hence in the presence of a positive FRT, this 
research indicates that a diagnosis of CGH is highly likely, and that other forms of 
headache are less likely. However in the absence of a positive test, it is important not 
to rule out the potential for CGH, as the FRT does not test other motion segments 
adequately or indeed other upper cervical structures.  
In clinical practice it is recommended that the FRT be used to complement 
other forms of examination to identify patients with CGH. The combination of 
cervical spine range of motion deficits, pain on palpation of the upper four cervical 
vertebra, and impairment identified by the craniocervical flexion test accurately 
identify patients with CGH (Jull 1997; Amiri et al 2007). Adding the FRT procedure 
to the physical examination of patients with headache, is likely to enhance the 
clinical decision making process.  
Measurement of the scale of range of motion deficit on the FRT also provides 
some indication of the severity of headache symptoms. This may be useful to 
measure improvement over time in headache interventional studies.  
Knowledge of impairment of the C1/2 segment also directs the 
physiotherapist to potential therapies, including the Mulligan Concept (Mulligan 
2010), passive accessory intervertebral motion (Jull et al 2002), and myofascial 
treatment techniques (Hopper et al 2006) among others. Techniques described by 
Mulligan (2006) have been shown to be helpful in the management of CGH in the 
short- and long-term in subjects with a positive FRT (Hall et al 2007). Intervention 
based on the Mulligan Concept improved FRT range of motion deficits immediately 
after the first application. Furthermore daily application of this intervention as a 
home exercise reduced headache symptoms over a 12-month period.  
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8.1 SUMMARY 
Headache is a common symptom, which is currently classified according to 
the underlying cause. Diagnosis is important, particularly for secondary headache, as 
a successful outcome is only likely if intervention is targeted to the underlying 
problem. 
As has been shown, those who suffer from headache frequently present with a 
range of different headache features, sometimes with more than one headache form 
in any individual. As each headache form arises from differing underlying 
pathophysiological processes, management for each condition must vary 
accordingly. For example CGH is know to respond to manipulative therapy. 
However, people with migraine or TTH do not respond to such forms of treatment. 
Hence, the identification of CGH is important to practitioners of manual therapy, as 
it informs the potential for treatment. 
The literature review has indicated that differentiating migraine from CGH is 
difficult as CGH and migraine share common features, including the presence of 
neck pain and perhaps altered cervical mobility. Consequently incorrect diagnosis of 
migraine is common, likely impacting on the effectiveness of management. Hence 
the major diagnostic challenge is to find accurate and reliable clinical means of 
identifying subjects with CGH.  
Cervical movement impairment is reported to be an important factor in CGH 
diagnosis. The FRT is an easily applied form of movement analysis, the aim of 
which is to identify movement impairment specifically at the C1/2 segment. The 
general aims of this doctoral research were to improve the understanding of the 
reliability, long-term stability, diagnostic accuracy, validity and clinical utility of the 
FRT in CGH diagnosis.  
 
8.1.1 Part A - Reliability and diagnostic accuracy of the FRT 
Study 1 found that, for experienced examiners, range of motion recorded and 
examiner interpretation of the FRT is stable over days and two-weeks. The minimal 
detectable change for range of motion recorded by the FRT is seven degrees. 
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Knowledge of the responsiveness of the FRT in differentiating CGH from 
migraine without aura, or MHF was not known and was the aim of Study 2. This 
study found that the FRT is significantly more restricted in subjects with CGH when 
compared with subjects with MHF or migraine. The cut-off scores for a positive FRT 
were 30˚. In these groups, the diagnostic value of the FRT had sensitivity of 0.7, 
specificity of 0.7, positive predictive value of 0.54, negative predictive value of 0.82, 
positive likelihood ratio of 2.33 and negative likelihood ratio of 0.43.  
It is important to recognize that the FRT is not positive in all patients with 
CGH. Only 70% of cases of CGH have a positive test. In those patients with a 
negative test other cervical segments or other cervical structures should be assessed 
before discounting a diagnosis of CGH. 
 
8.1.2 Part B – Validity of the flexion-rotation test 
Cervical spine range of motion deficit identified by active range of motion 
tests and the FRT are important diagnostic features of CGH and other cervical spine 
disorders. Movement in the cardinal planes provides information about movement 
impairment of the cervical spine as a whole, but not about specific segments. In 
contrast some examination techniques like the FRT are thought to assess movement 
at a specific cervical motion segment. The literature suggests that impairment 
identified by such tests should be used as an indicator to apply specific manipulative 
treatment techniques to the restricted cervical motion segment. In that case the aim is 
to reduce impairment and consequently decrease symptoms. The examination 
procedures themselves can also be used as outcome measures of treatment success 
following intervention to the specific impaired segment.  
The biconvex articular surfaces at the C1/2 segment are anatomically unique 
when compared to other joints in the spine. This anatomical arrangement allows 
cervical rotation to occur in any neck position, including end-range flexion. Hence 
biomechanical theory suggests that placing the cervical spine in end-range flexion 
during the FRT prevents movement at all motion segments apart from at the C1/2 
segment. 
The validity of the FRT as a test of C1/2 motion deficit has not been directly 
investigated. To our knowledge Study 3 is the first to measure in vivo cervical 
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segmental movements during the FRT to confirm the relative contribution of motion 
at the C1/2 segment to overall head and neck rotation. The results indicate that 75% 
of the total head/neck rotation during the FRT occurs at the C1/2 segment. The 
percentage contribution from C1/2 rises to approximately 90% of total rotation when 
considering only those cervical segments capable of causing headache (C0-4). In 
contrast negligible movement occurs at the C0/1 segment. 
A core principle of manual therapy assessment is that the pain provoked by 
segmental tests arises from the specific segment being tested. Additionally 
symptomatic motion segments other than the one under test should not influence 
range of motion determined by segmental tests. If the FRT is a specific test of C1/2 
impairment then symptomatic motion segments at levels other than C1/2 should not 
influence range recorded during the FRT. Study 4 found that the presence of 
symptomatic cervical segments below the C2 vertebra does not influence range of 
motion or interpretation of the FRT.  
 
8.1.3 Part C - Clinical utility of the flexion-rotation test 
The aim of Part C was to determine the clinical utility of the FRT in diagnosis 
and management of CGH. Two studies were conducted. Study 5 sought to identify 
the frequency with which each or multiple segments above the C4 vertebra were the 
dominant source of pain in subjects with CGH. Furthermore, the reliability of manual 
examination procedures was also investigated. The results of this study indicate that 
manual examination of the segments above the C4 vertebra was reliable. The present 
series of studies found that in subjects with CGH, the C1/2 segment was the most 
common symptomatic motion segment. Positive findings on manual examination 
were found at this level in 63% of cases. Following the C1/2 level, the next most 
common positive segment was C2/3, with 30% of cases. Only seven percent of cases 
were positive at the C0/1 segment and none were positive at the C3/4 segment. 
When examining patients with spinal pain, physiotherapists routinely assess 
range of movement. Limitation of movement is believed to correlate with pain and 
disability, and is therefore used to measure progress in rehabilitation. With regard to 
the FRT, two previous studies had investigated the relationship between impairment 
of movement and severity of CGH and provide conflicting evidence of association.  
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Study 6 investigated the relationship between impairment determined by the 
FRT and subject and headache characteristics. This study found that half the variance 
in FRT range of motion was explained by the presence of two variables: neck 
movement or positions that provoke headache, and neck symptoms that precede 
headache. Furthermore, range of motion recorded during the FRT was partly 
explained by an index of headache severity, as well as component parts of this index, 
comprising headache frequency, intensity and duration. Other subject and headache 
characteristics did not influence range of motion or interpretation of the FRT.  
Study 6 also found that the presence of headache at the time of testing reduces 
the range of motion during the FRT by a mean of six degrees. While this deficit does 
not affect examiner interpretation of the FRT, it does warrant caution when 
interpreting the FRT over time. It is important to consider the presence of symptoms 
at each test occasion when interpreting the results from the FRT. 
 
8.2 CONCLUSION 
The series of studies conducted in this doctoral research has highlighted the 
central role that the FRT should play in the diagnosis of CGH. CGH principally 
arises from dysfunction of the C1/2 segment, although usually more than one 
segment is involved. Determining dysfunction at the C1/2 segment can be reliably 
achieved by using the FRT as well as manual examination procedures. The FRT, in 
contrast to manual examination, is an easily applied clinical test that is reliable, when 
used by experienced or inexperienced examiners. Measurement and interpretation of 
the FRT is stable over time. Range recorded during the FRT is related to the severity 
of headache symptoms. The presence of pain arising from segments other than C1/2 
does not influence interpretation of the FRT. Finally, the similarity of headache 
characteristics but difference in cervical spine range of motion deficits (specifically 
the FRT) between those with migraine and those with CGH highlights the 
importance of the FRT in headache evaluation. 
 
Chapter 9 – References 
 163 
 References  
 
The International Classification of Headache Disorders: 2nd edition. Cephalalgia 
2004; 24 Suppl 1: 9-160. 
Amiri M, Jull G, Bullock-Saxton J. Measuring range of active cervical rotation in a 
position of full head flexion using the 3D Fastrak measurement system: an 
intra-tester reliability study. Manual Therapy 2003; 8(3): 176-179. 
Amiri M, Jull G, Bullock-Saxton J, Darnell R, Lander C. Cervical musculoskeletal 
impairment in frequent intermittent headache. Part 2: subjects with 
concurrent headache types. Cephalalgia 2007; 27(8): 891-898. 
Andrasik F, Lipchik GL, McCrory DC, Wittrock DA. Outcome measurement in 
behavioral headache research: headache parameters and psychosocial 
outcomes. Headache 2005; 45(5): 429-437. 
Antonaci F, Ghirmai S, Bono G, Sandrini G, Nappi G. Cervicogenic headache: 
evaluation of the original diagnostic criteria. Cephalalgia 2001; 21(5): 573-
583. 
April C, Axinn M, Bogduk N. Occipital headaches stemming from the lateral 
atlanto-axial (C1-2) joint. Cephalalgia 2002; 22: 15-22. 
Berg J, Stovner LJ. Economic evidence in migraine and other headaches: a review. 
European Journal of Health Economics 2004; 5: S43–S54. 
Bevilaqua-Grossi D, Pegoretti KS, Goncalves MC, Speciali JG, Bordini CA, Bigal 
ME. Cervical mobility in women with migraine. Headache 2009; 49(5): 726-
731. 
Bigal ME, Borucho S, Serrano D, Lipton RB. The acute treatment of episodic and 
chronic migraine in the USA. Cephalalgia 2009; 29(8): 891-897. 
Biondi DM. Physical treatments for headache: a structured review. Headache 2005; 
45(6): 738-746. 
Bogduk N, Govind J. Cervicogenic headache: an assessment of the evidence on 
clinical diagnosis, invasive tests, and treatment. Lancet Neurol 2009; 8(10): 
959-968. 
Borg-Stein J. Cervical myofascial pain and headache. Curr Pain Headache Rep 2002; 
6(4): 324-330. 
Chapter 9 – References 
 164 
Bovim G, Berg R, Dale LG. Cervicogenic headache: anesthetic blockades of cervical 
nerves (C2-C5) and facet joint (C2/C3). Pain 1992; 49(3): 315-320. 
Bronfort G, Haas M, Evans R, Leiniger B, Triano J. Effectiveness of manual 
therapies: the UK evidence report. Chiropr Osteopat 2010; 18(1): 3. 
Bronfort G, Nilsson N, Haas M, Evans R, Goldsmith CH, Assendelft WJ, Bouter 
LM. Non-invasive physical treatments for chronic/recurrent headache. 
Cochrane Database Syst Rev 2004;(3): CD001878. 
Buse DC, Andrasik F. Behavioral medicine for migraine. Neurol Clin 2009; 27(2): 
445-465. 
Buzzi M, Moskowitz M. The pathophysiology of migraine: year 2005. Journal of 
Headache Pain 2005; 6: 105-111. 
Calhoun AH, Ford S, Millen C, Finkel AG, Truong Y, Nie Y. The Prevalence of 
Neck Pain in Migraine. Headache 2010; 50(8): 1273-1277. 
Classification Committee of the International Headache Society. Classification and 
diagnostic criteria for headache disorders, cranial neuralgias and facial pain. 
Headache Classification Committee of the International Headache Society. 
Cephalalgia 1988; 8 Suppl 7: 1-96. 
Classification Committee of the International Headache Society. The International 
Classification of Headache Disorders: 2nd edition. Cephalalgia 2004; 24 
Suppl 1: 9-160. 
Crisco JJ, 3rd, Panjabi MM, Dvorak J. A model of the alar ligaments of the upper 
cervical spine in axial rotation. J Biomech 1991; 24(7): 607-614. 
Daffner SD, Xin J, Taghavi CE, Hymanson HJ, Mudiyam C, Hongyu W, Wang JC. 
Cervical segmental motion at levels adjacent to disc herniation as determined 
with kinetic magnetic resonance imaging. Spine (Phila Pa 1976) 2009; 
34(22): 2389-2394. 
Diener I. The impact of cervicogenic headache on patients attending a private 
physiotherapy practice in Cape Town. South African Journal of 
Physiotherapy 2001; 57(1): 35-39. 
Dodick D, Silberstein S. Central sensitization theory of migraine: clinical 
implications. Headache 2006; 46 Suppl 4: S182-191. 
Dodick DW. Pearls: Headache. Semin Neurol 2010; 30(1): 74-81. 
Chapter 9 – References 
 165 
Dumas JP, Arsenault AB, Boudreau G, Magnoux E, Lepage Y, Bellavance A, Loisel 
P. Physical impairments in cervicogenic headache: traumatic vs. 
nontraumatic onset. Cephalalgia 2001; 21(9): 884-893. 
Dvorak J. Epidemiology, physical examination, and neurodiagnostics. Spine 1998; 
23(24): 2663-2673. 
Dvorak J, Dvorak V. Manual medicine: Diagnostics. New York, Thieme Medical 
Publishers, 1990. 
Edmeads J, Findlay H, Tugwell P, Pryse-Phillips W, Nelson RF, Murray TJ. Impact 
of migraine and tension-type headache on life-style, consulting behaviour, 
and medication use: a Canadian population survey. Can J Neurol Sci 1993; 
20(2): 131-137. 
Eliasziw M, Young S, Woodbury M, Fryday-Field K. Statistical methodology for the 
concurrent assessment of interrater and intrarater reliability: using 
goniometric measurements as an example. Physical Therapy 1994; 74: 777-
788. 
Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power 
analysis program for the social, behavioral, and biomedical sciences. Behav 
Res Methods 2007; 39(2): 175-191. 
Fernandez-de-las-Penas C, Alonso-Blanco C, Cuadrado ML, Gerwin RD, Pareja JA. 
Trigger points in the suboccipital muscles and forward head posture in 
tension-type headache. Headache 2006; 46(3): 454-460. 
Fernandez-de-Las-Penas C, Alonso-Blanco C, Cuadrado ML, Miangolarra JC, 
Barriga FJ, Pareja JA. Are manual therapies effective in reducing pain from 
tension-type headache?: a systematic review. Clin J Pain 2006; 22(3): 278-
285. 
Fernandez-de-Las-Penas C, Alonso-Blanco C, Cuadrado ML, Pareja JA. Spinal 
manipulative therapy in the management of cervicogenic headache. Headache 
2005; 45(9): 1260-1263. 
Fernandez-de-las-Penas C, Alonso-Blanco C, Cuadrado ML, Pareja JA. Forward 
head posture and neck mobility in chronic tension-type headache: a blinded, 
controlled study. Cephalalgia 2006; 26(3): 314-319. 
Fernandez-de-Las-Penas C, Cuadrado ML, Pareja JA. Myofascial trigger points, 
neck mobility and forward head posture in unilateral migraine. Cephalalgia 
2006; 26(9): 1061-1070. 
Chapter 9 – References 
 166 
Fishbain DA, Cutler R, Cole B, Rosomoff HL, Rosomoff RS. International Headache 
Society headache diagnostic patterns in pain facility patients. Clin J Pain 
2001; 17(1): 78-93. 
Flahault, A., M. Cadilhac, et al.. Sample size calculation should be performed for 
design accuracy in diagnostic test studies." J Clin Epidemiol
Fletcher JP, Bandy WD. Intrarater reliability of CROM measurement of cervical 
spine active range of motion in persons with and without neck pain. J Orthop 
Sports Phys Ther 2008; 38(10): 640-645. 
 2005; 58(8): 
859-62 
Freund BJ, Schwartz M. Treatment of chronic cervical-associated headache with 
botulinum toxin A: a pilot study. Headache 2000; 40(3): 231-236. 
Friedman BW, Hochberg ML, Esses D, Grosberg B, Corbo J, Toosi B, Meyer RH, 
Bijur PE, Lipton RB, Gallagher EJ. Applying the International Classification 
of Headache Disorders to the emergency department: an assessment of 
reproducibility and the frequency with which a unique diagnosis can be 
assigned to every acute headache presentation. Ann Emerg Med 2007; 49(4): 
409-419, 419 e401-409. 
Gantenbein AR, Sandor PS. Physiological parameters as biomarkers of migraine. 
Headache 2006; 46(7): 1069-1074. 
Gibbs TS, Fleischer AB, Jr., Feldman SR, Sam MC, O'Donovan CA. Health care 
utilization in patients with migraine: demographics and patterns of care in the 
ambulatory setting. Headache 2003; 43(4): 330-335. 
Goadsby PJ, Charbit AR, Andreou AP, Akerman S, Holland PR. Neurobiology of 
migraine. Neuroscience 2009; 161(2): 327-341. 
Goadsby PJ, Zagami AS, Lambert GA. Neural processing of craniovascular pain: a 
synthesis of the central structures involved in migraine. Headache 1991; 
31(6): 365-371. 
Granella F, D'Alessandro R, Manzoni GC, Cerbo R, Colucci D'Amato C, Pini LA, 
Savi L, Zanferrari C, Nappi G. International Headache Society classification: 
interobserver reliability in the diagnosis of primary headaches. Cephalalgia 
1994; 14(1): 16-20. 
Gross AR, Hoving JL, Haines TA, Goldsmith CH, Kay T, Aker P, Bronfort G. A 
Cochrane review of manipulation and mobilization for mechanical neck 
disorders. Spine 2004; 29(14): 1541-1548. 
Chapter 9 – References 
 167 
Haas M, Schneider M, Vavrek D. Illustrating risk difference and number needed to 
treat from a randomized controlled trial of spinal manipulation for 
cervicogenic headache. Chiropr Osteopat 2010a; 18(1): 9. 
Haas M, Spegman A, Peterson D, Aickin M, Vavrek D. Dose response and efficacy 
of spinal manipulation for chronic cervicogenic headache: a pilot randomized 
controlled trial. Spine J 2010b; 10(2): 117-128. 
Hagen K, Einarsen C, Zwart JA, Svebak S, Bovim G. The co-occurrence of headache 
and musculoskeletal symptoms amongst 51 050 adults in Norway. Eur J 
Neurol 2002; 9(5): 527-533. 
Hagen KB, Harms-Ringdahl K, Enger NO, Hedenstad R, Morten H. Relationship 
between subjective neck disorders and cervical spine mobility and motion-
related pain in male machine operators. Spine 1997; 22(13): 1501-1507. 
Hall T, Chan HT, Christensen L, Odenthal B, Wells C, Robinson K. Efficacy of a 
C1-C2 self-sustained natural apophyseal glide (SNAG) in the management of 
cervicogenic headache. J Orthop Sports Phys Ther 2007; 37(3): 100-107. 
Hall T, Robinson K. The flexion-rotation test and active cervical mobility--a 
comparative measurement study in cervicogenic headache. Manual Therapy 
2004; 9(4): 197-202. 
Hall T, Robinson K, Fujinawa O, Kiyokazu A (2007). The influence of examiner 
experience on interpretation of the cervical flexion-rotation test. 15th 
International World Confederation for Physical Therapy, Vancouver. 
Hall T, Robinson K, Ogince M (2003). Cervicogenic headache - Which motion 
segments are involved? 13th Biennial conference of the Musculoskeletal 
Physiotherapists Association of Australia, Sydney, Australia. 
Hall TM, Briffa K, Hopper D. Clinical evaluation of cervicogenic headache. Journal 
of Manual and Manipulative Therapy 2008; 16(2): 73-80. 
Hall TM, Briffa K, Hopper D. Comparative analysis of the flexion rotation test in 
migraine, cervicogenic headache and mixed headache forms. Journal of 
Headache and Pain 2010; DOI 10.1007/s10194-010-0222-3. 
Hall TM, Briffa K, Hopper D. The relationship between cervicogenic headache 
subjective features and impairment determined by the cervical flexion-
rotation test. Submitted 2010. 
Chapter 9 – References 
 168 
Hall TM, Briffa K, Hopper D, Robinson KW. Intratester reliability and minimal 
detectable change of the cervical flexion-rotation test. Journal of Orthopadic 
& Sports Physical Therapy 2010; 40(4): 225-229. 
Hall TM, Robinson KW, Fujinawa O, Akasaka K, Pyne EA. Intertester reliability 
and diagnostic validity of the cervical flexion-rotation test. J Manipulative 
Physiol Ther 2008; 31(4): 293-300. 
Harpole LH, Samsa GP, Matchar DB, Silberstein SD, Blumenfeld A, Jurgelski AE. 
Burden of illness and satisfaction with care among patients with headache 
seen in a primary care setting. Headache 2005; 45(8): 1048-1055. 
Hawkins K, Wang S, Rupnow M. Direct cost burden among insured US employees 
with migraine. Headache 2008; 48(4): 553-563. 
Hershey AD. Current approaches to the diagnosis and management of paediatric 
migraine. Lancet Neurol 2010; 9(2): 190-204. 
Hopper D, Bajaj Y, Choi L, Jan O, Hall T, Robinson K. Does a Specific Soft Tissue 
Intervention to the Upper Cervical Spine Improve Cervicogenic Headache 
Symptoms and Range of Motion in the Flexion-Rotation Test? School of 
Physiotherapy. Perth, Curtin University, 2006. 
Hu H, Markson L, Lipton R, Stewart W, Berger M. Burden of migraine in the United 
States—disability and economic costs. Archives of Internal Medicine 1999; 
1: 813-818. 
International Headache Society. International Headache Society. ICD-10 Guide for 
headaches. Cephalalgia 1997; 17: 1-91. 
Jaeger B. Are "cervicogenic" headaches due to myofascial pain and cervical spine 
dysfunction? Cephalalgia 1989; 9(3): 157-164. 
Jensen S. Neck related causes of headache. Aust Fam Physician 2005; 34(8): 635-
639. 
Jull G. Management of cervical headache. Man Ther 1997; 2(4): 182-190. 
Jull G, Amiri M, Bullock-Saxton J, Darnell R, Lander C. Cervical musculoskeletal 
impairment in frequent intermittent headache. Part 1: Subjects with single 
headaches. Cephalalgia 2007; 27(7): 793-802. 
Jull G, Trott P, Potter H, Zito G, Neire K, Shirley D, Emberson J, Marschner I, 
Richardson C. A randomized controlled trial of exercise and manipulative 
therapy for cervicogenic headache. Spine 2002; 27(17): 1835-1843. 
Chapter 9 – References 
 169 
Kang S, Lee W, Moon J, Chun S. Correlation of spinal mobility with severity of 
chronic lower back pain. Yonsei Medical Journal 1995; 36(1): 37-36. 
Kidd R, Nelson C. Musculoskeletal Dysfunction of the Neck in Migraine and 
Tension Headache. Headache 1993; 33: 566-569. 
Kirchmann M. Migraine with aura: new understanding from clinical epidemiologic 
studies. Curr Opin Neurol 2006; 19(3): 286-293. 
Lambert GA, Hoskin KL, Zagami AS. Cortico-NRM influences on trigeminal 
neuronal sensation. Cephalalgia 2008; 28(6): 640-652. 
Landis J, Koch G. The measurement of observer agreement for categorical data. 
Biometrics 1977; 33(1): 159–174. 
Lee H, Nicholson LL, Adams RD. Cervical range of motion associations with 
subclinical neck pain. Spine 2004; 29(1): 33-40. 
Leone M, D'Amico D, Grazzi L, Attanasio A, Bussone G. Cervicogenic headache: a 
critical review of the current diagnostic criteria. Pain 1998; 78(1): 1-5. 
Lipton RB, Bigal ME, Kolodner K, Stewart WF, Liberman JN, Steiner TJ. The 
family impact of migraine: population-based studies in the USA and UK. 
Cephalalgia 2003; 23(6): 429-440. 
Lipton RB, Diamond S, Reed M, Diamond ML, Stewart WF. Migraine diagnosis and 
treatment: results from the American Migraine Study II. Headache 2001; 
41(7): 638-645. 
MacGregor EA, Brandes J, Eikermann A, Giammarco R. Impact of migraine on 
patients and their families: the Migraine And Zolmitriptan Evaluation 
(MAZE) survey--Phase III. Curr Med Res Opin 2004; 20(7): 1143-1150. 
Maitland G, Hengeveld E, Banks K, English K. Maitland's vertebral manipulation. 
6th Edn. London, Butterworth Heinemann, 2001. 
Marcus DA, Scharff L, Mercer S, Turk DC. Musculoskeletal abnormalities in 
chronic headache: a controlled comparison of headache diagnostic groups. 
Headache 1999; 39(1): 21-27. 
Martelletti P, Steiner TJ, Bertolote JM, Dua T, Saraceno B. The definitive position of 
headache among the major public health challenges. An end to the slippery 
slope of disregard. J Headache Pain 2007; 8(3): 149-151. 
Martins IP, Baeta E, Paiva T, Campos J, Gomes L. Headaches during intracranial 
endovascular procedures: a possible model of vascular headache. Headache 
1993; 33(5): 227-233. 
Chapter 9 – References 
 170 
May A, Buchel C, Turner R, Goadsby PJ. Magnetic resonance angiography in facial 
and other pain: neurovascular mechanisms of trigeminal sensation. J Cereb 
Blood Flow Metab 2001; 21(10): 1171-1176. 
Miyazaki M, Hong SW, Yoon SH, Zou J, Tow B, Alanay A, Abitbol JJ, Wang JC. 
Kinematic analysis of the relationship between the grade of disc degeneration 
and motion unit of the cervical spine. Spine (Phila Pa 1976) 2008; 33(2): 187-
193. 
Miyazaki M, Hymanson HJ, Morishita Y, He W, Zhang H, Wu G, Kong MH, 
Tsumura H, Wang JC. Kinematic analysis of the relationship between sagittal 
alignment and disc degeneration in the cervical spine. Spine (Phila Pa 1976) 
2008; 33(23): E870-876. 
Moeller JJ, Kurniawan J, Gubitz GJ, Ross JA, Bhan V. Diagnostic accuracy of 
neurological problems in the emergency department. Can J Neurol Sci 2008; 
35(3): 335-341. 
Monaghan M. Spinal manipulation: a manual for physiotherapists. Nelson, New 
Zealand, Aesculapius Ltd, 2001. 
Moore MK. Upper crossed syndrome and its relationship to cervicogenic headache. J 
Manipulative Physiol Ther 2004; 27(6): 414-420. 
Morishita Y, Hida S, Miyazaki M, Hong SW, Zou J, Wei F, Naito M, Wang JC. The 
effects of the degenerative changes in the functional spinal unit on the 
kinematics of the cervical spine. Spine (Phila Pa 1976) 2008; 33(6): E178-
182. 
Morishita Y, Hymanson H, Miyazaki M, Zhang HH, He W, Wu G, Kong MH, Wang 
JC. Kinematic evaluation of the spine: a kinetic magnetic resonance imaging 
study. J Orthop Surg (Hong Kong) 2008; 16(3): 348-350. 
Morishita Y, Naito M, Hymanson H, Miyazaki M, Wu G, Wang JC. The relationship 
between the cervical spinal canal diameter and the pathological changes in 
the cervical spine. Eur Spine J 2009; 18(6): 877-883. 
Moskowitz MA. Basic mechanisms in vascular headache. Neurol Clin 1990; 8(4): 
801-815. 
Mueller LL. Diagnosing and managing migraine headache. J Am Osteopath Assoc 
2007; 107(10 Suppl 6): ES10-16. 
Mulligan B. Manual therapy - "NAGS", "SNAGS", MWMS" etc. 5th edn. 
Wellington, Plane View Services, 2006. 
Chapter 9 – References 
 171 
Mulligan B. Manual therapy - "NAGS", "SNAGS", MWMS" etc. 6th edn. 
Wellington, Plane View Services, 2010. 
Nattrass CL, Nitschke JE, Disler PB, Chou MJ, Ooi KT. Lumbar spine range of 
motion as a measure of physical and functional impairment: an investigation 
of validity. Clin Rehabil 1999; 13(3): 211-218. 
Nelson CF, Bronfort G, Evans R, Boline P, Goldsmith C, Anderson AV. The 
efficacy of spinal manipulation, amitriptyline and the combination of both 
therapies for the prophylaxis of migraine headache. J Manipulative Physiol 
Ther 1998; 21(8): 511-519. 
Nichols FT, 3rd, Mawad M, Mohr JP, Hilal S, Adams RJ. Focal headache during 
balloon inflation in the vertebral and basilar arteries. Headache 1993; 33(2): 
87-89. 
Niere K. Central nervous system processing in cervicogenic headache. Headache, 
orofacial pain and bruxism. Selvaratnam, PJ, Niere K and Zuluaga M. 
Edinburgh, Elsevier, 2009: 95-114. 
Niere K, Robinson P. Determination of manipulative physiotherapy treatment 
outcome in headache patients. Manual Therapy 1997; 2(4): 199-205. 
Ogince M, Hall T, Robinson K, Blackmore AM. The diagnostic validity of the 
cervical flexion-rotation test in C1/2-related cervicogenic headache. Man 
Ther 2007; 12(3): 256-262. 
Oksanen A, Metsahonkala L, Viander S, Jappila E, Aromaa M, Anttila P, Salminen 
J, Sillanpaa M. Strength and mobility of the neck-shoulder region in 
adolescent headache. Physiother Theory Pract 2006; 22(4): 163-174. 
Olesen J. Are headache disorders caused by neurobiological mechanisms? Curr Opin 
Neurol 2006; 19(3): 277-280. 
Olesen J. The role of nitric oxide (NO) in migraine, tension-type headache and 
cluster headache. Pharmacol Ther 2008; 120(2): 157-171. 
Olesen J, Steiner T, Bousser MG, Diener HC, Dodick D, First MB, Goadsby PJ, 
Gobel H, Lainez MJ, Lipton RB, Nappi G, Sakai F, Schoenen J, Silberstein 
SD. Proposals for new standardized general diagnostic criteria for the 
secondary headaches. Cephalalgia 2009; 29(12): 1331-1336. 
Panjabi M, Dvorak J, Crisco J, 3rd, Oda T, Hilibrand A, Grob D. Flexion, extension, 
and lateral bending of the upper cervical spine in response to alar ligament 
transections. J Spinal Disord 1991; 4(2): 157-167. 
Chapter 9 – References 
 172 
Pellechia G, Bohannon R. Active lateral flexion range of motion measurements 
obtained with a modified goniometer: reliability and estimates of normal. 
Journal of Manipulative and Physiological Therapeutics 1998; 21: 443-447. 
Petersen C, Johnson R, Schuit D. Reliability of cervical range of motion using the 
OSI CA 6000 Spine Motion Analyser on asymptomatic and symptomatic 
subjects. Manual Therapy 2000; 5: 82-88. 
Pfaffenrath V, Kaube H. Diagnostics of cervicogenic headache. Functional 
Neurology 1990; 5: 159-164. 
Pransky GS, Berndt E, Finkelstein SN, Verma S, Agrawal A. Performance 
decrements resulting from illness in the workplace: the effect of headaches. J 
Occup Environ Med 2005; 47(1): 34-40. 
Radtke A, Neuhauser H. Prevalence and burden of headache and migraine in 
Germany. Headache 2009; 49(1): 79-89. 
Rasmussen BK, Olesen J. Migraine with aura and migraine without aura: an 
epidemiological study. Cephalalgia 1992; 12(4): 221-228; discussion 186. 
Robertson BA, Morris ME. The role of cervical dysfunction in migraine: a 
systematic review. Cephalalgia 2008; 28(5): 474-483. 
Roth JK, Roth RS, Weintraub JR, Simons DG. Cervicogenic headache caused by 
myofascial trigger points in the sternocleidomastoid: a case report. 
Cephalalgia 2007; 27(4): 375-380. 
Russell MB, Olesen J. A nosographic analysis of the migraine aura in a general 
population. Brain 1996; 119 ( Pt 2): 355-361. 
Schoonman GG, Evers DJ, Terwindt GM, van Dijk JG, Ferrari MD. The prevalence 
of premonitory symptoms in migraine: a questionnaire study in 461 patients. 
Cephalalgia 2006; 26(10): 1209-1213. 
Schurks M, Buring JE, Kurth T. Migraine, Migraine Features, and Cardiovascular 
Disease. Headache 2010; 50(6): 1036-1040 
Schweitzer S. The economics of migraine. The American Journal of Managed Care 
1999; 5(2): S91-S98. 
Scottish Intercollegiate Guideline Network. Diagnosis and management of headache 
in adults, Scottish Intercollegiate Guideline Network, 2008. 107. 
Sim J, Wright CC. The kappa statistic in reliability studies: use, interpretation, and 
sample size requirements. Phys Ther 2005; 85(3): 257-268. 
Chapter 9 – References 
 173 
Sjaastad O, Bakketeig LS. Migraine without aura: comparison with cervicogenic 
headache. Vaga study of headache epidemiology. Acta Neurol Scand 2007. 
Sjaastad O, Bakketeig LS. Prevalence of cervicogenic headache: Vaga study of 
headache epidemiology. Acta Neurol Scand 2007. 
Sjaastad O, Fredriksen TA, Pfaffenrath V. Cervicogenic headache: diagnostic 
criteria. The Cervicogenic Headache International Study Group. Headache 
1998; 38(6): 442-445. 
Smedmark V, Wallin M, Arvidsson I. Inter-examiner reliability in assessing passive 
intervertebral motion of the cervical spine. Man Ther 2000; 5(2): 97-101. 
Smith K, Hall T, Robinson K. The influence of age, gender, lifestyle factors and sub-
clinical neck pain on cervical range of motion. Manual Therapy 2007; 13: 
552-559. 
Smith TR, Nicholson RA, Banks JW. Migraine Education Improves Quality of Life 
in a Primary Care Setting. Headache 2010; 50(4): 600-612 
Stang PE, Crown WH, Bizier R, Chatterton ML, White R. The family impact and 
costs of migraine. Am J Manag Care 2004; 10(5): 313-320. 
Steiner TJ. Lifting the burden: The global campaign against headache. Lancet Neurol 
2004; 3(4): 204-205. 
Steiner TJ, Scher AI, Stewart WF, Kolodner K, Liberman J, Lipton RB. The 
prevalence and disability burden of adult migraine in England and their 
relationships to age, gender and ethnicity. Cephalalgia 2003; 23(7): 519-527. 
Sterling M, Jull G, Carlsson Y, Crommert L. Are cervical physical outcome 
measures influenced by the presence of symptomatology? Physiother Res Int 
2002; 7(3): 113-121. 
Stewart AL, Hays RD, Ware JE, Jr. The MOS short-form general health survey. 
Reliability and validity in a patient population. Med Care 1988; 26(7): 724-
735. 
Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache 
in the United States. Relation to age, income, race, and other 
sociodemographic factors. JAMA 1992; 267(1): 64-69. 
Stochkendahl M, Christensen H, Hartvigsen J, Vach W, Haas M, Hestbaek L, Adams 
A, Bronfort G. Manual Examination of the spine: A systematic review of 
reproducibility. Journal of Manipulative & Physiological Therapeutics 2006; 
29: 475-485. 
Chapter 9 – References 
 174 
Stovner L, Hagen K, Jensen R, Katsarava Z, Lipton R, Scher A, Steiner T, Zwart J. 
The global burden of headache: a documentation of headache prevalence and 
disability worldwide. Cephalalgia 2007; 27: 193–210. 
Stovner LJ, Andree C. Impact of headache in Europe: a review for the Eurolight 
project. J Headache Pain 2008; 9(3): 139-146. 
Stovner LJ, Hagen K. Prevalence, burden, and cost of headache disorders. Curr Opin 
Neurol 2006; 19(3): 281-285. 
Stratton S, Bryan J. Dysfunction, evaluation, and treatment of the cervical spine and 
thoracic inlet. Orthopaedic Physical Therapy. R, D and MJ W. New York, 
Churchill Livingstone, 1994: 77-122. 
Takasaki H, Hall T, Kaneko S, Iizawa T, Ikemoto Y. Cervical segmental motion 
induced by shoulder abduction assessed by magnetic resonance imaging. 
Spine (Phila Pa 1976) 2009; 34(3): E122-126. 
Tegeler CH, Davidai G, Gengo FM, Knappertz VA, Troost BT, Gabriel H, Davis 
RL. Middle cerebral artery velocity correlates with nitroglycerin-induced 
headache onset. J Neuroimaging 1996; 6(2): 81-86. 
Tenhunen K, Elander J. A qualitative analysis of psychological processes mediating 
quality of life impairments in chronic daily headache. J Health Psychol 2005; 
10(3): 397-407. 
Tepper SJ, Dahlof CG, Dowson A, Newman L, Mansbach H, Jones M, Pham B, 
Webster C, Salonen R. Prevalence and diagnosis of migraine in patients 
consulting their physician with a complaint of headache: data from the 
Landmark Study. Headache 2004; 44(9): 856-864. 
Urban MO, Gebhart GF. Supraspinal contributions to hyperalgesia. Proc Natl Acad 
Sci U S A 1999; 96(14): 7687-7692. 
van Suijlekom JA, de Vet HC, van den Berg SG, Weber WE. Interobserver 
reliability of diagnostic criteria for cervicogenic headache. Cephalalgia 1999; 
19(9): 817-823. 
van Trijffel E, Anderegg Q, Bossuyt PM, Lucas C. Inter-examiner reliability of 
passive assessment of intervertebral motion in the cervical and lumbar spine: 
a systematic review. Man Ther 2005; 10(4): 256-269. 
Vincent MB, Luna RA. Cervicogenic headache: a comparison with migraine and 
tension-type headache. Cephalalgia 1999; 19 Suppl 25: 11-16. 
Chapter 9 – References 
 175 
Walmsley RP, Kimber P, Culham E. The effect of initial head position on active 
cervical axial rotation range of motion in two age populations. Spine 1996; 
21(21): 2435-2442. 
Wittrock DA, Foraker SL. Tension-type headache and stressful events: the role of 
selective memory in the reporting of stressors. Headache 2001; 41(5): 482-
493. 
World Health Organization. World Health Report 2001. Geneva, WHO, 2001: 28. 
Yi X, Cook AJ, Hamill-Ruth RJ, Rowlingson JC. Cervicogenic headache in patients 
with presumed migraine: missed diagnosis or misdiagnosis? J Pain 2005; 
6(10): 700-703. 
Ylinen J, Takala EP, Kautiainen H, Nykanen M, Hakkinen A, Pohjolainen T, Karppi 
SL, Airaksinen O. Association of neck pain, disability and neck pain during 
maximal effort with neck muscle strength and range of movement in women 
with chronic non-specific neck pain. Eur J Pain 2004; 8(5): 473-478. 
Zito G, Jull G, Story I. Clinical tests of musculoskeletal dysfunction in the diagnosis 
of cervicogenic headache. Manual Therapy 2006; 11(2): 118-129. 
Zwart JA. Neck mobility in different headache disorders. Headache 1997; 37(1): 6-
11. 
Zwart JA, Sand T. Repeatability of dermatomal warm and cold sensory thresholds in 
patients with sciatica. Eur Spine J 2002; 11(5): 441-446. 
 
Every reasonable effort has been made to acknowledge the owners of copyright 
material. I would be pleased to hear from any copyright owner who has been omitted 
or incorrectly acknowledged. 
 
Chapter 10 – Appendix 
 176 
  
Chapter 10 – Appendix 
 177 
 
 
 Chapter 10: Appendix 
  
Chapter 10 – Appendix 
 178 
 
 
Chapter 10 – Appendix 
 179 
10.1 APPENDIX 1: ETHICAL ISSUES 
 
The Human Research Ethics Committee, Curtin University of Technology, 
approved Studies 1, 2, 4, 5, and 6. The Society of Physical Therapy Science in Japan 
approved Study 3.  
 
The ethical issues in these studies were addressed by the following means: 
• To ensure informed consent the subjects were given a written information sheet 
explaining the nature of the study and the procedures involved prior to testing 
(see section 10.1.1). Subjects were asked to read the information sheet, and if 
willing to participate, to sign the consent form (see section 10.1.2). 
• Subjects were able to withdraw from the study at any time without prejudice. 
• To ensure anonymity - each subject was allocated a number, which was used to 
identify the subject for subsequent analysis. All data was recorded on 
computer. Subject numbers, but not names, accompanied data. Subjects could 
not be identified by their individual results and only aggregate data was used 
for reporting purposes. 
• The risks associated with the study were explained to the subjects. Subjects 
were informed that they would experience mild discomfort from the FRT and 
manual examination, with consequent short-term (24-hour) symptom 
exacerbation in a small proportion of individuals. Such exacerbation would be 
consistent with any form of physical examination procedure. The subjects were 
given the opportunity of contacting the Principal Investigator if any problems 
arose during or persisted after testing.  
• In Study 4, subjects received lower cervical facet block procedures, as part of 
medical management by their treating medical practitioner. These block 
procedures were not given as part of the study protocol, hence no additional 
risk was taken by subjects who took part in this study.   
Time commitment – In Study 1 subjects were required to make a time 
commitment of 20-minutes on a maximum of five occasions. For Study 5, 1.5 hours 
was required on a single occasion. For the remaining Studies, subjects were required 
to make a time commitment of a maximum of 30-minutes, also on a single occasion.  
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Benefits to subjects - when individual problems were identified, education 
and advice was given, and where needed a follow up referral to a physiotherapist was 
recommended. 
Benefits to the wider community- the results of the study will allow a better 
understanding of physical examination procedures used in headache diagnosis. Due 
to the overlap of symptoms seen between CGH and migraine, both conditions are 
frequently misdiagnosed. Consequently, it is likely that treatment is unsubstantiated 
and a poor prognosis will follow. Thus, there is a need to determine physical tests 
that are valid, reliable and sensitive in assisting the diagnosis of CGH. These tests 
may then provide more objective means of determining clinical outcomes and 
thereby determining and improving treatment efficacy. Improving headache 
diagnosis and treatment may also have positive beneficial effects in reducing the 
significant cost burden of headache to society. Study results will be made available 
to the physiotherapy community via publication in appropriate journals and 
conference presentations.  
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10.1.1 Subject Information Form – Study 1 
Title of Project:  Reliability of the cervical flexion-rotation test over time – a 
longitudinal study 
Investigator:  Toby Hall (PhD candidate), Specialist Musculoskeletal 
Physiotherapist, School of Physiotherapy, Curtin University of 
Technology, WA. Telephone: 0412851385 
Supervisors: Associate Professor Kathy Briffa & Associate Professor Diana 
Hopper, School of Physiotherapy, Curtin University of 
Technology. Telephone: 9266 3666 
Purpose of Study 
Neck related headaches account for 20% of all chronic headaches. The flexion-
rotation test (FRT) is a commonly used test in physiotherapy practice that is used to 
identify restriction of neck movement at a specific point in the upper neck. This test 
has been shown to be valuable in diagnosis of neck headaches, and is also used as a 
means of evaluating effectiveness of treatments applied to the neck. The purpose of 
this study is to investigate the variability of measurement of the FRT over time (days 
and weeks). An additional purpose is to see if the presence of a headache at the time 
of testing alters interpretation of the FRT. Results obtained from this research will 
help physiotherapists to gain a better understanding of the reliability of the FRT and 
will expand upon the current knowledge of the clinical utility of the FRT in neck 
headache evaluation. 
 
Procedures 
If you agree to be involved in this study, you will be required to visit Curtin 
University of Technology, School of Physiotherapy on five occasions within a two-
week period. Each session will take approximately 20-minutes. 
 
Visit #1 – Induction Session and first FRT assessment 
Upon arrival, you will be required to complete the consent form below. Following 
this you will be allocated an identification number to be used for all data collection. 
You will receive instructions about what the FRT will involve and be able to ask 
questions of the investigator. An experienced physiotherapist will perform the FRT 
on each occasion. Prior to testing the physiotherapist will attach a measurement 
device to your head for recording of movement during the testing procedure. The 
FRT will then be performed. While lying on your back your neck will be tilted 
forward so that your chin moves towards your chest. Your head will be turned to the 
left and right as far as it can go without discomfort.  
 
Visit #2 - #4– FRT assessment 
Two-days, four-days and two-weeks after your first visit you will need to return to 
the School of Physiotherapy for repeat evaluation of the FRT. The procedure will be 
exactly as for visit #1. 
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Visit #5 – FRT assessment during headache attack 
You will need to attend the School of Physiotherapy for an additional evaluation of 
the FRT during a headache attack. You will be asked to contact the investigator at 
the onset of your headache to schedule at the earliest opportunity a final evaluation 
of the FRT. The procedure will be exactly as for visit #1. 
 
The following sections are repeated in Studies 1, 2 4, 5 and 6.  
 
Risks, Discomforts and Benefits: 
There are no intended adverse effects associated with this Study. There is a small 
possibility that the procedure may trigger a headache or neck pain, however these 
symptoms should be of minor duration. The results obtained from this Study will 
help expand physiotherapist’s current knowledge of physical examination procedures 
of the neck and in neck headache evaluation. 
 
Confidentiality: 
You will be allocated an identification number that will remain confidential to the 
investigator and the project supervisors. All recorded data will be entered in an excel 
program, on a computer using your identification number only, no names will be 
used. Access to the stored data will be restricted by a password known only by the 
investigators and the project supervisor. All data collected and consent forms will be 
stored safely in a locked cupboard at the Curtin School of Physiotherapy. 
The results of the Study will be reported on, although it will not be possible to 
identify individual subjects as no identification numbers or names will be included in 
report material. On completion of the Study, all data will be stored in a secure and 
confidential location with the project supervisor for five years. After this time, all 
data will be destroyed. This is a Curtin University of Technology requirement. 
 
Request for Further Information: 
You are encouraged to discuss and/or express any concerns or questions regarding 
this study with the investigator at any time. You should feel confident and secure 
about your involvement in the study. 
 
Refusal or Withdrawal: 
You may refuse to participate in the Study and if you do consent to participate then 
you will be free to withdraw from the Study at any time without fear or prejudice. If 
you do decide to withdraw from the Study at any time please contact the 
investigators at the earliest possible convenience. All data will be destroyed if you do 
decide to withdraw. 
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Approval 
This study has been approved by the Curtin University Human Research Ethics 
Committee. The committee is comprised of members of the public, academic, 
lawyers, doctors & pastoral carers. Its main role is to protect participants. If needed, 
verification of approval can be obtained either by writing to the Curtin University 
Human Research Ethics Committee, c/-Office of Research and Development, Curtin 
University of Technology, GPO Box U1987, Perth, 6845 or by telephoning 9266 
2784 or by emailing hrec@curtin.edu.au
 
.  
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10.1.2 Subject Consent Form – Studies 1, 2, 4, 5, and 6 
Title of Project:  Studies 1, 2, 4, 5, and 6 
 
Investigators:  Toby Hall (PhD candidate), Specialist Musculoskeletal 
Physiotherapist, School of Physiotherapy, Curtin University of 
Technology, WA. Telephone: 0412851385 
 
Project Supervisor:  Associate Professor Kathy Briffa & Associate Professor Diana 
Hopper, School of Physiotherapy, Curtin University of 
Technology. Telephone: 9266 3666. 
 
You are of your own accord making a decision whether or not to participate in this 
research study. Your signature verifies that you have decided to participate in the 
study, having read and understood all the information accessible. Your signature also 
officially states that you have had adequate opportunity to discuss this Study with the 
investigators and all your questions have been answered to your satisfaction. You 
will be given a copy of this consent document to keep.   
I, (the undersigned) 
_______________________________________________________(Please PRINT) 
of 
____________________________________________________________________ 
Postcode _____________________  Phone __________________________ 
consent to involvement in this Study and give my authorization for any results from 
this Study to be used in any research paper, on the understanding that confidentiality 
will be maintained. I understand that participation in this Study may cause me a mild 
headache. I comprehend that I may withdraw from the Study at any time without 
discrimination. If so, I undertake to contact Toby Hall (Tel. 0412851385) at the 
earliest opportunity. 
 
Signature _________________________  Date _______________ 
 
                Subject 
I have explained to the subject the procedures of the Study to which the subject has 
consented their involvement and have answered all questions. In my appraisal, the 
subject has voluntarily and intentionally given informed consent and possesses the 
legal capacity to give informed consent to participate in this research Study. 
 
 
Principal Investigator:  ___________________     Date:  ______________ 
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10.1.3 Subject Information Form – Study 2 
Title of Project:  Is the flexion-rotation test positive in sufferers of migraine 
without aura? 
Investigator:  Toby Hall 
Supervisors: Associate Professor K Briffa & Associate Professor D Hopper 
 
Purpose of Study 
Neck related headaches account for 20% of all chronic headaches. There is much 
similarity between another common headache, migraine headache, and neck related 
headache. Identification of the headache type is made in part on the symptoms as 
well as by physical examination of the neck. The flexion-rotation test (FRT) is a 
commonly used test in physiotherapy practice that is used to identify restriction of 
neck movement at a specific point in the upper neck and has been shown to be 
positive in 80% of cases of neck headache. This test may therefore be a useful means 
of differentiating neck headache from migraine headache. The purpose of this Study 
is to investigate different aspects of the FRT in subjects with migraine and subjects 
with neck headache. The results obtained from this research will help 
physiotherapists to gain a better understanding of the relationship between the FRT 
and headache and will therefore expand upon the current knowledge of the clinical 
utility of the FRT in headache evaluation. 
 
Procedures 
If you agree to be involved in this study, you will be required to visit Curtin 
University of Technology, School of Physiotherapy on one occasion. The session 
will take approximately 20-minutes. 
 
Induction Session and assessment 
Upon arrival, you will be required to complete the consent form below. Following 
this you will be allocated an identification number to be used for all data collection. 
You will receive instructions about what manual examination testing procedure will 
involve and be able to ask questions of the investigator. An experienced 
physiotherapist will perform the FRT. Prior to testing the physiotherapist will attach 
a measurement device to your head for recording of movement during the testing 
procedure. The FRT will then be performed. While lying on your back your neck 
will be tilted forward so that your chin moves towards your chest. Your head will be 
turned to the left and right as far as it can go without discomfort. Following this 
procedure you will be asked to fill out a simple questionnaire regarding the your 
headache. 
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10.1.4 Subject Information and Consent Form – Study 3 
This information form and consent form was translated into Japanese language. 
 
Title of Project:  Normal kinematics of the upper cervical spine during the 
Flexion-Rotation Test – in vivo measurements using Magnetic 
Resonance Imaging 
Investigators:  Hiroshi Takasaki, Toby Hall, Sadanori Oshiro, Shouta Kaneko, 
Yoshikazu Ikemoto and Gwendolen Jull 
 
Purpose of Study 
Neck related headaches account for 20% of all chronic headaches. There is much 
similarity between another common headache, migraine headache, and neck related 
headache. Identification of the headache type is made in part on the symptoms as 
well as by physical examination of the neck. The flexion-rotation test (FRT) is a 
commonly used test in physiotherapy practice that is used to identify restriction of 
neck movement at a specific point in the upper neck and has been shown to be 
positive in 80% of cases of neck headache. This test may therefore be a useful means 
of differentiating neck headache from migraine headache. The purpose of this study 
is to use Magnetic resonance imaging (MRI) to investigate movement of the neck 
during the FRT. The results obtained from this research will help physiotherapists to 
gain a better understanding of the validity of the FRT and will therefore expand upon 
the current knowledge of the clinical utility of the FRT in headache evaluation.  
 
Procedures 
If you agree to be involved in this study, you will be required to visit the MRI 
department at Shinoro Orthopaedic on one occasion. The session will take 
approximately 60-minutes. Upon arrival, you will be required to complete the 
consent form below. Following this you will be allocated an identification number to 
be used for all data collection. You will receive instructions about the testing 
procedure and you will be able to ask questions of the investigator. A physiotherapist 
will perform a routine examination of your neck. Following this you will be asked to 
lay on your back in the MRI machine and images taken with your neck in different 
positions. Firstly your head/neck will be rotated to the left and right, as far as it can 
go without discomfort, and held at end range while the MRI scans your neck. 
Following this your neck will be tilted forward so that your chin moves towards your 
chest. Your head will be turned to the left and right again as far as it can go without 
discomfort, again while the MRI scans your neck.  
 
Risks, Discomforts and Benefits: 
There are no intended adverse effects associated with this study. The results obtained 
from this study will help expand physiotherapist’s current knowledge of physical 
examination procedures of the neck and in neck headache evaluation. 
 
Chapter 10 – Appendix 
 187 
Confidentiality: 
You will be allocated an identification number that will remain confidential to the 
investigator and the project supervisors. All recorded data will be entered on to a 
computer using your identification number only, and no names will be used.  
The results of the study will be reported on, although it will not be possible to 
identify individual subjects as no identification numbers or names will be included in 
report material. On completion of the study, all data will be securely stored with the 
project investigator for 5 years. 
 
Request for Further Information: 
You are encouraged to discuss and/or express any concerns or questions regarding 
this study with the investigator at any time. You should feel confident and secure 
about your involvement in the study. 
 
Refusal or Withdrawal: 
You may refuse to participate in the study and if you do consent to participate then 
you will be free to withdraw from the study at any time without fear or prejudice. If 
you do decide to withdraw from the study at any time please contact the investigators 
at the earliest possible convenience. All data will be destroyed if you do decide to 
withdraw. 
 
Approval 
This study has been granted approval by the Society of Physical Therapy Science in 
Japan.  
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10.1.5 Subject Consent Form – Study 3 
Title of Project:  Normal kinematics of the upper cervical spine during the 
Flexion-Rotation Test – in vivo measurements using Magnetic 
Resonance Imaging 
Investigators:  Hiroshi Takasaki, Toby Hall, Sadanori Oshiro, Shouta Kaneko, 
Yoshikazu Ikemoto and Gwendolen Jull 
 
You are of your own accord making a decision whether or not to participate in this 
research study. Your signature verifies that you have decided to participate in the 
study, having read and understood all the information accessible. Your signature also 
officially states that you have had adequate opportunity to discuss this study with the 
investigators and all your questions have been answered to your satisfaction. You 
will be given a copy of this consent document to keep.   
 
I, (the undersigned) 
_______________________________________________________(Please PRINT) 
of 
____________________________________________________________________ 
 
consent to involvement in this study and give my authorization for any results from 
this study to be used in any research paper, on the understanding that confidentiality 
will be maintained. I comprehend that I may withdraw from the study at any time 
without discrimination. If so, I undertake to contact Hiroshi Takasaki at the earliest 
opportunity. 
 
Signature _________________________  Date _______________ 
 
                Subject 
 
I have explained to the subject the procedures of the study to which the 
subject has consented their involvement and have answered all questions. In my 
appraisal, the subject has voluntarily and intentionally given informed consent and 
possesses the legal capacity to give informed consent to participate in this research 
study. 
 
 
Principal Investigator:  ___________________     Date:  ______________ 
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10.1.6 Subject Information Form - Study 4 
Title of Project:  The influence of lower cervical joint pain on sensitivity and 
specificity of the FRT in CGH evaluation 
Investigator:  Toby Hall (PhD candidate), Specialist Musculoskeletal 
Physiotherapist, School of Physiotherapy, Curtin University of 
Technology, WA. Telephone: 0412851385 
Supervisors: Associate Professor Kathy Briffa & Associate Professor Diana 
Hopper, School of Physiotherapy, Curtin University of 
Technology. Telephone: 9266 3666 
 
Purpose of Study 
Neck related headaches account for 20% of all chronic headaches. The flexion-
rotation test (FRT) is a commonly used test in physiotherapy practice that is used to 
identify restriction of neck movement at a specific point in the upper neck. This test 
has been shown to be valuable in diagnosis of neck related headaches, and is also 
used as a means of evaluating effectiveness of treatments applied to the neck. The 
purpose of this study is to investigate whether pain and joint disorders arising from 
the lower neck influence the FRT. Results obtained from this research will help 
physiotherapists to gain a better understanding of the reliability of the FRT and will 
expand upon the current knowledge of the clinical utility of the FRT in neck 
headache evaluation. 
You are being invited to participate in this study because you have been scheduled to 
have a pain relieving procedure to your neck in the near future. If you decide to 
participate we will compare the results of your neck procedure with our findings 
from the FRT. 
 
Procedures 
If you agree to be involved in this study, you will be required to visit Curtin 
University of Technology, School of Physiotherapy on one occasion. This session 
will take approximately 20 minutes. 
 
Induction Session and FRT assessment 
Upon arrival, you will be asked to complete the consent form below. Following this 
you will be allocated an identification number to be used for all data collection. You 
will receive instructions about what the FRT will involve and be able to ask 
questions of the investigator. An experienced physiotherapist will perform the FRT. 
Prior to testing the physiotherapist will attach a measurement device to your head for 
recording of movement during the testing procedure. The FRT will then be 
performed. While lying on your back your neck will be tilted forward, so that your 
chin moves towards your chest either to the end range or to the point at which 
discomfort arises. Your head will be turned to the left and right as far as it can go 
without discomfort. You will then be free to leave. We will contact you by telephone 
shortly after your pain relieving procedure, to find out what effects this had on your 
symptoms. 
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10.1.7 Subject Information Form – Study 5 
Title of Project:  Frequency of C1/2 segmental dysfunction as a cause of 
cervicogenic headache 
Investigator:  Toby Hall (PhD candidate), Specialist Musculoskeletal 
Physiotherapist, School of Physiotherapy, Curtin University of 
Technology, WA. Telephone: 0412851385 
Supervisors: Associate Professor Kathy Briffa & Associate Professor Diana 
Hopper, School of Physiotherapy, Curtin University of 
Technology. Telephone: 9266 3666 
 
Purpose of Study 
Neck related headaches account for 20% of all chronic headaches. Identification of 
which part of the neck causes the headache is important as it directs treatment and 
also highlights the specific area physiotherapists should focus on in their 
examination. Manual examination, which consists of a number of tests to identify the 
pain source in the neck, has been shown to be valuable in diagnosis of neck related 
headache. Testing consists of gentle passive movement of the neck. The purpose of 
this study is to investigate which part of the neck is the predominant cause of neck 
related headache. Results obtained from this research will help physiotherapists to 
gain a better understanding of the source of neck related headache, optimize 
examination and may help direct treatment. 
 
Procedures 
If you agree to be involved in this study, you will be required to visit Curtin 
University of Technology, School of Physiotherapy on one occasion. The session 
will take approximately 20-minutes. 
 
Induction Session and assessment 
Upon arrival, you will be required to complete the consent form below. Following 
this you will be allocated an identification number to be used for all data collection. 
You will receive instructions about what manual examination testing procedure will 
involve and be able to ask questions of the investigator. Two experienced 
physiotherapists will separately perform some gentle tests on your neck. While lying 
on your back with your head on a pillow, the physiotherapists will passively move 
your neck in various directions while feeling for movement at various points in your 
neck. Following this you will be asked to lie on your stomach while your neck will 
be gently palpated and enquiry made as to any discomfort generated.  
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10.1.8 Subject Information Form – Study 6 
Title of Project:  The relationship between cervicogenic headache subjective 
features and impairment determined by the cervical flexion-
rotation test 
Investigator:  Toby Hall (PhD candidate), Specialist Musculoskeletal 
Physiotherapist, School of Physiotherapy, Curtin University of 
Technology, WA. Telephone: 0412851385 
Supervisors: Associate Professor Kathy Briffa & Associate Professor Diana 
Hopper, School of Physiotherapy, Curtin University of 
Technology. Telephone: 9266 3666 
 
Purpose of Study 
Neck related headaches account for 20% of all chronic headaches. The flexion-
rotation test (FRT) is a commonly used test in physiotherapy practice that is used to 
identify restriction of neck movement at a specific point in the upper neck. This test 
has been shown to be valuable in diagnosis of neck headaches, and is also used as a 
means of evaluating effectiveness of treatments applied to the neck. The purpose of 
this study is to investigate the relationship between the FRT and headache 
symptoms. Results obtained from this research will help physiotherapists to gain a 
better understanding of the relationship between the FRT and headache and will 
therefore expand upon the current knowledge of the clinical utility of the FRT in 
neck headache evaluation. 
 
Procedures 
If you agree to be involved in this study, you will be required to visit Curtin 
University of Technology, School of Physiotherapy on one occasion. The session 
will take approximately 20-minutes. 
 
10.1.9 Induction Session and FRT assessment 
Upon arrival, you will be required to complete the consent form below. Following 
this you will be allocated an identification number to be used for all data collection. 
You will receive instructions about what the FRT will involve and be able to ask 
questions of the investigator. An experienced physiotherapist will perform the FRT. 
Prior to testing the physiotherapist will attach a measurement device to your head for 
recording of movement during the testing procedure. The FRT will then be 
performed. While lying on your back your neck will be tilted forward so that your 
chin moves towards your chest. Your head will be turned to the left and right as far 
as it can go without discomfort. Following this procedure you will be asked to fill out 
a simple questionnaire regarding the your headache. 
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10.2  MEMORANDUM CONFIRMING ETHICAL APPROVAL 
FOR EACH STUDY 
 
The memoranda confirming ethical approval for each study conducted in Australia 
are shown in the following section. 
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10.2.1 Ethical approval Study 1 
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10.2.2 Ethical approval Study 2 
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10.2.3 Ethical approval Study 4 
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10.2.4 Ethical approval Study 5 
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10.2.5 Ethical approval Study 6 
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10.3 APPENDIX 2 - QUESTIONNAIRES 
 
All subjects with headache were assessed for details regarding their headache. 
 
10.3.1 Headache severity index questionnaire 
This questionnaire sourced from Niere and Robinson (1997) 
 
1. Frequency of headaches 
 
Fewer 
than 1 
per 
month 
1 per 
month 
2-3 per 
month 
1 per 
week 
2-3 per 
week 
4-5 per 
week 
Daily More 
than 1 
per day 
Ο Ο Ο Ο Ο Ο Ο Ο 
 
2. Average intensity of headaches 
 
Choose ONE spot along this row which best represents the average intensity of the 
headaches 
 
 
ΟΟΟΟΟΟΟΟΟΟΟΟΟΟΟΟΟΟΟΟΟΟΟΟΟΟΟΟΟ  
 
 
3.Average duration of headaches 
 
Less than 
1 hour 
1-2 hours 3-5 hours 6-8 hours 9-12 
hours 
13-24 
hours 
1-2 days More 
than 2 
days 
Ο Ο Ο Ο Ο Ο Ο Ο 
 
Worst 
Possible 
pain 
No 
pain 
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10.3.2 Headache Classification Questionnaire 
 
Please mark on the chart your symptoms, describing the quality of each symptom. 
 
 
Your age =   Gender = Male ⎔   Female   ⎔   
Headache side = Left ⎔ Right ⎔  Both ⎔     Worst = Left ⎔ or Right  ⎔ 
A. For how long have you been experiencing headache?  =                 years 
 
A1. Frequency of headaches 
 
Few than 
1 per 
month 
1 per 
month 
2-3 per 
month 
1 per 
week 
2-3 per 
week 
4-5 per 
week 
Daily More than 
1 per day 
        
 
A2. Average intensity of headaches 
Choose the ONE spot along this row which best represents the average 
intensity of the headaches 
 
No pain 
 
                        
Worst 
possible pain 
No. 
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A3. Average duration of headaches 
 
Less than 
1 hour 
1-2 hours 3-5 hours 6-8 hours 9-12 
hours 
13-24 
hours 
1-2 days More than 
2 days 
        
 
 
B1. Do you associate any of the following with your headache: 
Nausea  ⎔ Vomiting    ⎔  Tinnitus (ringing in the ears) ⎔ 
Blurred vision ⎔ Watery eye ⎔  Pins & needles or numbness ⎔ 
 
B2. Does headache pain start in your neck? YES ⎔ NO ⎔    Or head YES ⎔  NO ⎔ 
Does your headache change from side to side during an episode?  YES ⎔  NO ⎔ 
Does your headache vary in duration?   YES ⎔     NO ⎔ 
 
B3. Do you have any warning signs before your headache starts?  YES ⎔ NO ⎔ 
B4. How long do the warning signs last?  Hours….          Minutes……   
B5. If you have warning signs please describe them...................................................... 
 
B6. If you have warning signs does your headache start immediately? YES ⎔  NO ⎔ 
 
B7. How did your headache first start: 
a) An accident (eg, motor car, sporting, fall)  YES ⎔ NO ⎔ 
b) Following illness. YES ⎔ NO ⎔ 
c) Following stress YES ⎔ NO ⎔ 
d) Prolonged sessions at the computer  YES ⎔ NO ⎔ 
e) Following adverse events, please specify ……… YES ⎔ NO ⎔ 
f) Other  YES ⎔ NO ⎔ 
g) Cannot relate to anything  YES ⎔ NO ⎔ 
C. EFFECT OF MEDICATION ON YOUR HEADACHE 
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C1. Please give an indication how much medication you use in an effort to control 
your headache.  
Type of medication Average 
tablets per 
month 
Days taking 
medication 
per month 
Name/Brand of 
medication (If 
known to you) 
“Over the counter” medication    
Prescribed medication    
Injections for pain    
 
D.  TRIGGERING OR AGGRAVATING FACTORS 
Which of the following may trigger or aggravate your headache. Please mark the 
appropriate box 
 
 Never Seldom Mostly Always 
D1. Noise; Loud music; Banging 
 
    
D2. Bright light; Sunshine; flashing lights 
     
D3. Sustained neck postures/positions: sitting 
at computer, driving, watch TV etc     
D4. Neck movements: head turning, looking 
up, etc     
D5. Alcoholic drinks: red wine 
     
D6. Foods: Chocolates, Preservatives, etc 
     
D7. Tension; Pressure; Stress 
 
    
D8. Physical activity e.g. walking up stairs, 
brisk walking, running     
D9. Menstruation 
     
D10 Others - Please specify 
     
E.  EASING FACTORS 
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E1.   Is there anything you can do to reduce your headache?  YES ⎔  NO ⎔ 
 
Which of the following relieves your headache. Please mark the appropriate box 
 
 Never Seldom Mostly Always 
E1. Find an easing position for your neck     
E2. Support your neck     
E3. Take medication     
E4. Others - Please specify     
 
 
